</p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>As<br /> filed with the Securities and Exchange Commission on November 25,<br /> 2020</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: RIGHT"> <span>Registration<br /> No. 333-       </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; TEXT-ALIGN: CENTER"> <span> </span></p> <p><!-- FIELD: RULE-PAGE --></p> <p><!-- FIELD: /RULE-PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>UNITED<br /> STATES</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>SECURITIES<br /> AND EXCHANGE COMMISSION</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Washington,<br /> DC 20549</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>FORM<br /> S-3</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>REGISTRATION<br /> STATEMENT</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Under</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>THE<br /> SECURITIES ACT OF 1933</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>MICROBOT<br /> MEDICAL INC.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span>(Exact<br /> name of Registrant as specified in its charter)</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 49%; TEXT-ALIGN: CENTER"> <span><b>Delaware</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 2%; TEXT-ALIGN: CENTER"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 49%; TEXT-ALIGN: CENTER"> <span><b>94-3078125</b></span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: CENTER"> <span>(State<br /> or other jurisdiction of</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: CENTER"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: CENTER"> <span>(I.R.S.<br /> Employer</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: CENTER"> <span>Incorporation<br /> or organization)</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: CENTER"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: CENTER"> <span>Identification<br /> No.)</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>25<br /> Recreation Park Drive, Unit 108</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Hingham,<br /> Massachusetts 02043</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>(781)<br /> 875-3605</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span>(Address,<br /> including zip code, and telephone number, including area code, of<br /> Registrant’s principal executive offices)</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Harel<br /> Gadot</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Chairman,<br /> President and Chief Executive Officer</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>25<br /> Recreation Park Drive, Unit 108</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Hingham,<br /> MA 02043</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>(781)<br /> 875-3605</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span>(Name,<br /> address, including zip code, and telephone number, including area<br /> code, of agent for service)</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b><i><br /> Copy to:</i></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 50%"> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Marc<br /> D. Mantell, Esq.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Mintz,<br /> Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>One<br /> Financial Center</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Boston,<br /> MA 02111</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>(617)<br /> 542-6000</b></span></p> </td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 50%"> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Stephen<br /> E. Fox, Esq.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Ruskin<br /> Moscou Faltischek, P.C.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>1425<br /> RXR Plaza</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>East<br /> Tower, 15<sup>th</sup> Floor</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Uniondale,<br /> New York 11556-1425</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>(516)<br /> 663-6600</b></span></p> </td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Approximate<br /> date of commencement of proposed sale to the public:</b> From time<br /> to time after the effective date of this registration statement, as<br /> determined by the Registrant.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>If<br /> the only securities being registered on this Form are being offered<br /> pursuant to dividend or interest reinvestment plans, please check<br /> the following box: [  ]</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>If<br /> any of the securities being registered on this Form are to be<br /> offered on a delayed or continuous basis pursuant to Rule 415 under<br /> the Securities Act of 1933, other than securities offered only in<br /> connection with dividend or interest reinvestment plans, check the<br /> following box: [X]</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>If<br /> this Form is filed to register additional securities for an<br /> offering pursuant to Rule 462(b) under the Securities Act, please<br /> check the following box and list the Securities Act registration<br /> statement number of the earlier effective registration statement<br /> for the same offering. [  ]</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>If<br /> this Form is a post-effective amendment filed pursuant to Rule<br /> 462(c) under the Securities Act, check the following box and list<br /> the Securities Act registration statement number of the earlier<br /> effective registration statement for the same offering.<br /> [  ]</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>If<br /> this form is a registration statement pursuant to General<br /> Instruction I.D. or a post-effective amendment thereto that shall<br /> become effective upon filing with the Commission pursuant to Rule<br /> 462(e) under the Securities Act, check the following box.<br /> [  ]</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>If<br /> this form is a post-effective amendment to a registration statement<br /> filed pursuant General Instruction I.D. filed to register<br /> additional securities or additional classes of securities pursuant<br /> to Rule 413(b) under the Securities Act, check the following box.<br /> [  ]</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>Indicate<br /> by check mark whether the registrant is a large accelerated filer,<br /> an accelerated filer, a non-accelerated filer, a smaller reporting<br /> company, or an emerging growth company. See the definitions of<br /> “large accelerated filer,” “accelerated filer,” “smaller reporting<br /> company” and “emerging growth company” in Rule 12b-2 of the<br /> Exchange Act.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="WIDTH: 80%; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="TEXT-ALIGN: CENTER; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 40%"> <span>Large<br /> Accelerated Filer</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; TEXT-ALIGN: JUSTIFY"> <span>[  ]</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 40%"> <span>Accelerated<br /> Filer</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%"> <span>[  ]</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="TEXT-ALIGN: CENTER; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"> <span>Non-Accelerated<br /> Filer</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>[X]</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Smaller<br /> Reporting Company</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>[X]</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Emerging<br /> Growth Company</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>[  ]</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>CALCULATION<br /> OF REGISTRATION FEE</b></span></p> <p style="TEXT-ALIGN: CENTER; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT"> <span> </span></p> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"> <tr style="VERTICAL-ALIGN: BOTTOM"> <td style="FONT-WEIGHT: BOLD; TEXT-ALIGN: CENTER; BORDER-BOTTOM: BLACK 1.5PT SOLID"> <span>Title of<br /> Each Class of Securities to be Registered</span></td> <td style="PADDING-BOTTOM: 1.5PT"><span> </span></td> <td colspan="2" style="TEXT-ALIGN: CENTER; BORDER-BOTTOM: BLACK 1.5PT SOLID"> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER"> <span><b>Amount<br /> to be</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER"> <span><b>Registered</b></span></p> </td> <td style="PADDING-BOTTOM: 1.5PT"><span> </span></td> <td style="PADDING-BOTTOM: 1.5PT"><span> </span></td> <td colspan="2" style="TEXT-ALIGN: CENTER; BORDER-BOTTOM: BLACK 1.5PT SOLID"> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER"> <span><b>Proposed<br /> Maximum</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER"> <span><b>Offering Price<br /> Per</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER"> <span><b>Share</b></span></p> </td> <td style="PADDING-BOTTOM: 1.5PT"><span> </span></td> <td style="FONT-WEIGHT: BOLD; PADDING-BOTTOM: 1.5PT"><span> </span></td> <td colspan="2" style="FONT-WEIGHT: BOLD; TEXT-ALIGN: CENTER; BORDER-BOTTOM: BLACK 1.5PT SOLID"> <span>Proposed<br /> Maximum<br />Aggregate Offering Price</span></td> <td style="PADDING-BOTTOM: 1.5PT; FONT-WEIGHT: BOLD"><span> </span></td> <td style="PADDING-BOTTOM: 1.5PT"><span> </span></td> <td colspan="2" style="TEXT-ALIGN: CENTER; BORDER-BOTTOM: BLACK 1.5PT SOLID"> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER"> <span><b>Amount<br /> of</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER"> <span><b>Registration<br /> Fee<sup>(1)</sup></b></span></p> </td> <td style="PADDING-BOTTOM: 1.5PT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td><span>Common<br /> Stock, $0.01 par value</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>        </span></td> <td style="TEXT-ALIGN: LEFT"><span>(2)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>          </span></td> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>—</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE"> <td><span>Preferred Stock, $0.01<br /> par value</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(2)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>—</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td><span>Warrants</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(2)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>—</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE"> <td style="TEXT-ALIGN: LEFT"><span>Debt<br /> Securities</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(2)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>—</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td><span>Rights</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(2)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>—</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE"> <td><span>Units</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(2)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"/> <td style="TEXT-ALIGN: LEFT"><span>(3)</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>—</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td style="WIDTH: 30%"><span>Total</span></td> <td style="WIDTH: 1%"><span> </span></td> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span> </span></td> <td style="WIDTH: 10%; TEXT-ALIGN: RIGHT"/> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span> </span></td> <td style="WIDTH: 1%"><span> </span></td> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span> </span></td> <td style="WIDTH: 16%; TEXT-ALIGN: RIGHT"/> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span> </span></td> <td style="WIDTH: 1%"><span> </span></td> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span>$</span></td> <td style="WIDTH: 16%; TEXT-ALIGN: RIGHT"><span>75,000,000</span></td> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span> </span></td> <td style="WIDTH: 1%"><span> </span></td> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span>$</span></td> <td style="WIDTH: 16%; TEXT-ALIGN: RIGHT"><span>8,182.50</span></td> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span> </span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>(1)</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Calculated<br /> pursuant to Rule 457(o) under the Securities Act of 1933, as<br /> amended, based on the proposed maximum aggregate offering<br /> price.</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>(2)</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>There<br /> are being registered hereunder such indeterminate number of shares<br /> of common stock and preferred stock, such indeterminate principal<br /> amount of debt securities, such indeterminate number of warrants<br /> and rights to purchase common stock, preferred stock or debt<br /> securities, and such indeterminate number of units, as shall have<br /> an aggregate initial offering price not to exceed $75,000,000. If<br /> any debt securities are issued at an original issue discount, then<br /> the offering price of such debt securities shall be in such greater<br /> principal amount as shall result in an aggregate initial offering<br /> price not to exceed $75,000,000, less the aggregate dollar amount<br /> of all securities previously issued hereunder. Any securities<br /> registered hereunder may be sold separately or as units with other<br /> securities registered hereunder. The proposed maximum initial<br /> offering price per unit will be determined, from time to time, by<br /> the registrant in connection with the issuance by the registrant of<br /> the securities registered hereunder. The securities registered also<br /> include such indeterminate number of shares of common stock and<br /> preferred stock and amount of debt securities as may be issued upon<br /> conversion of or exchange for preferred stock or debt securities<br /> that provide for conversion or exchange, upon exercise of warrants<br /> or rights or pursuant to the anti-dilution provisions of any such<br /> securities. In addition, pursuant to Rule 416 under the Securities<br /> Act of 1933, as amended, the shares being registered hereunder<br /> include such indeterminate number of shares of common stock and<br /> preferred stock as may be issuable with respect to the shares being<br /> registered hereunder as a result of stock splits, stock dividends<br /> or similar transactions.</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>(3)</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><br /> The proposed maximum aggregate offering price per class of security<br /> will be determined from time to time by the registrant in<br /> connection with the issuance by the registrant of the securities<br /> registered hereunder and is not specified as to each class of<br /> security pursuant to General Instruction II.D. of Form S-3 under<br /> the Securities Act of 1933, as amended.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -13.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><br /> <b>The Registrant hereby amends this registration statement on such<br /> date or dates as may be necessary to delay its effective date until<br /> the Registrant shall file a further amendment which specifically<br /> states that this registration statement shall thereafter become<br /> effective in accordance with Section 8(</b></span><b><span>a<span>)<br /> of the Securities Act of 1933, AS AMENDED, or until THE<br /> registration statement shall become effective on such date as the<br /> SECURITIES AND EXCHANGE Commission, acting pursuant to SAID Section<br /> 8(</span>a<span>), may<br /> determine.</span></span></b></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p><!-- FIELD: RULE-PAGE --></p> <p><!-- FIELD: /RULE-PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 1 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><br /> <b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><br /> <b>The information in this prospectus is not complete and may be<br /> changed. WE MAY NOT SELL These securities until the registration<br /> statement filed with the Securities and Exchange Commission is<br /> effective. This prospectus is not an offer to sell these securities<br /> AND IS NOT soliciting AN OFFER to buy these securities in any<br /> jurisdiction where the offer or sale is not<br /> permitted.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span><br />  </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span><br /> <b>SUBJECT TO COMPLETION, DATED NOVEMBER 25, 2020</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>PROSPECTUS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><img src="https://content.edgar-online.com/edgar_conv_img/2020/11/25/0001493152-20-022541_LOGO_001.JPG" alt="" style="HEIGHT: 183PX; WIDTH: 365PX"/></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>$75,000,000</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Common<br /> Stock</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Preferred<br /> Stock</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Warrants</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Debt<br /> Securities</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Rights</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>Units</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>This<br /> prospectus will allow us to issue, from time to time at prices and<br /> on terms to be determined at or prior to the time of the offering,<br /> up to $75,000,000 of any combination of the securities described in<br /> this prospectus, either individually or in units. We may also offer<br /> common stock or preferred stock upon conversion of or exchange for<br /> the debt securities; common stock upon conversion of or exchange<br /> for the preferred stock; or common stock, preferred stock or debt<br /> securities upon the exercise of warrants or rights.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>This<br /> prospectus describes the general terms of these securities and the<br /> general manner in which these securities will be offered. We will<br /> provide you with the specific terms of any offering in one or more<br /> supplements to this prospectus. The prospectus supplements will<br /> also describe the specific manner in which these securities will be<br /> offered and may also supplement, update or amend information<br /> contained in this document. You should read this prospectus and any<br /> prospectus supplement, as well as any documents incorporated by<br /> reference into this prospectus or any prospectus supplement,<br /> carefully before you invest.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> securities may be sold directly by us to you, through agents<br /> designated from time to time or to or through underwriters or<br /> dealers. For additional information on the methods of sale, you<br /> should refer to the section entitled “Plan of Distribution” in this<br /> prospectus and in the applicable prospectus supplement. If any<br /> underwriters or agents are involved in the sale of our securities<br /> with respect to which this prospectus is being delivered, the names<br /> of such underwriters or agents and any applicable fees, commissions<br /> or discounts and over-allotment options will be set forth in a<br /> prospectus supplement. The price to the public of such securities<br /> and the net proceeds that we expect to receive from such sale will<br /> also be set forth in a prospectus supplement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 27.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> common stock is listed on The Nasdaq Capital Market under the<br /> symbol “MBOT.” On November 24, 2020, the last reported sale price<br /> of our common stock on The Nasdaq Capital Market was $7.25 per<br /> share. The applicable prospectus supplement will contain<br /> information, where applicable, as to any other listing, if any, on<br /> The Nasdaq Capital Market or any securities market or other<br /> securities exchange of the securities covered by the prospectus<br /> supplement. Prospective purchasers of our securities are urged to<br /> obtain current information as to the market prices of our<br /> securities, where applicable.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 27.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span><b>Investing<br /> in our securities involves a high degree of risk. Before deciding<br /> whether to invest in our securities, you should consider carefully<br /> the risks that we have described on page 4 of this prospectus under<br /> the caption “Risk Factors.” We may include specific risk factors in<br /> supplements to this prospectus under the caption “Risk Factors.”<br /> This prospectus may not be used to sell our securities unless<br /> accompanied by a prospectus supplement.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 27.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span><b>Neither<br /> the Securities and Exchange Commission nor any state securities<br /> commission has approved or disapproved of these securities or<br /> determined if this prospectus is truthful or complete. Any<br /> representation to the contrary is a criminal<br /> offense.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 27.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span>The<br /> date of this prospectus is<br />                ,<br /> 2020.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 2 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b><u><br /> TABLE OF CONTENTS</u></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: RIGHT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> This prospectus is part of a registration statement that we filed<br /> with the Securities and Exchange Commission, or SEC, utilizing a<br /> “shelf” registration process. Under this shelf registration<br /> process, we may offer shares of our common stock or preferred<br /> stock, various series of debt securities and/or warrants or rights<br /> to purchase any of such securities, either individually or in<br /> units, in one or more offerings, with a total value of up to<br /> $75,000,000. This prospectus provides you with a general<br /> description of the securities we may offer. Each time we offer a<br /> type or series of securities under this prospectus, we will provide<br /> a prospectus supplement that will contain specific information<br /> about the terms of that offering.</p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>This<br /> prospectus does not contain all of the information included in the<br /> registration statement. For a more complete understanding of the<br /> offering of the securities, you should refer to the registration<br /> statement, including its exhibits. The prospectus supplement may<br /> also add, update or change information contained or incorporated by<br /> reference in this prospectus. However, no prospectus supplement<br /> will offer a security that is not registered and described in this<br /> prospectus at the time of its effectiveness. This prospectus,<br /> together with the applicable prospectus supplements and the<br /> documents incorporated by reference into this prospectus, includes<br /> all material information relating to the offering of securities<br /> under this prospectus. You should carefully read this prospectus,<br /> the applicable prospectus supplement, the information and documents<br /> incorporated herein by reference and the additional information<br /> under the headings “Where You Can Find More Information” and<br /> “Incorporation of Documents by Reference” before making an<br /> investment decision.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>You<br /> should rely only on the information we have provided or<br /> incorporated by reference in this prospectus or any prospectus<br /> supplement. We have not authorized anyone to provide you with<br /> information different from that contained or incorporated by<br /> reference in this prospectus. No dealer, salesperson or other<br /> person is authorized to give any information or to represent<br /> anything not contained or incorporated by reference in this<br /> prospectus. You must not rely on any unauthorized information or<br /> representation. This prospectus is an offer to sell only the<br /> securities offered hereby, but only under circumstances and in<br /> jurisdictions where it is lawful to do so. You should assume that<br /> the information in this prospectus or any prospectus supplement is<br /> accurate only as of the date on the front of the document and that<br /> any information we have incorporated herein by reference is<br /> accurate only as of the date of the document incorporated by<br /> reference, regardless of the time of delivery of this prospectus or<br /> any sale of a security.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> further note that the representations, warranties and covenants<br /> made by us in any agreement that is filed as an exhibit to any<br /> document that is incorporated by reference in this prospectus were<br /> made solely for the benefit of the parties to such agreement,<br /> including, in some cases, for the purpose of allocating risk among<br /> the parties to such agreements, and should not be deemed to be a<br /> representation, warranty or covenant to you. Moreover, such<br /> representations, warranties or covenants were accurate only as of<br /> the date when made. Accordingly, such representations, warranties<br /> and covenants should not be relied on as accurately representing<br /> the current state of our affairs.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>This<br /> prospectus may not be used to consummate sales of our securities<br /> unless it is accompanied by a prospectus supplement. To the extent<br /> there are inconsistencies between any prospectus supplement, this<br /> prospectus and any documents incorporated by reference, the<br /> document with the most recent date will control.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Unless<br /> the context indicates otherwise in this prospectus, the terms<br /> “Microbot,” the “Company,” “we,” “our” or “us” in this prospectus<br /> refer to Microbot Medical Inc. and its wholly-owned<br /> subsidiaries.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 3 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>PROSPECTUS SUMMARY</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span><i>This<br /> summary highlights selected information about our Company, the<br /> offering of our securities under this prospectus and information<br /> appearing elsewhere in this prospectus and in the documents we<br /> incorporate by reference. This summary is not complete and does not<br /> contain all the information that you should consider before<br /> investing in our securities. You should read this entire prospectus<br /> carefully, including “Risk Factors” contained in this prospectus<br /> beginning on page 4, and the more detailed financial statements,<br /> notes to the consolidated financial statements and other<br /> information incorporated by reference from our filings with the SEC<br /> or included in any applicable prospectus supplement. Investing in<br /> our securities involves risks. Therefore, carefully consider the<br /> risk factors set forth in any prospectus supplement and in our most<br /> recent annual and quarterly filings with the SEC, as well as other<br /> information in this prospectus and any prospectus supplements and<br /> the documents incorporated by reference herein or therein, before<br /> purchasing our securities. Each of the risk factors could adversely<br /> affect our business, operating results and financial condition, as<br /> well as adversely affect the value of an investment in our<br /> securities.</i></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Overview</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Microbot<br /> is a pre-clinical medical device company specializing in the<br /> research, design and development of next generation robotic<br /> endoluminal surgery devices targeting the minimally invasive<br /> surgery space. Microbot is primarily focused on leveraging its<br /> micro-robotic technologies with the goal of redefining surgical<br /> robotics while improving surgical outcomes for patients.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Microbot’s<br /> current technological platforms, ViRob<sup>TM</sup>,<br /> TipCAT<sup>TM</sup> and Liberty™ (including certain CardioSert<br /> assets), are comprised of proprietary innovative technologies.<br /> Using the ViRob platform, Microbot is currently developing the Self<br /> Cleaning Shunt, or SCS<sup>TM</sup>, for the treatment of<br /> hydrocephalus and Normal Pressure Hydrocephalus, or NPH. Utilizing<br /> the Liberty and CardioSert platforms, Microbot is developing the<br /> first ever fully disposable robot for various endovascular<br /> interventional procedures. In addition, the Company is focused on<br /> the development of a Multi Generation Pipeline Portfolio utilizing<br /> all of its proprietary technologies.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Microbot<br /> has a patent portfolio of 40 issued/allowed patents and 23 patent<br /> applications pending worldwide.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Technological<br /> Platforms</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><i>ViRob</i></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>The<br /> ViRob is an autonomous crawling micro-robot which can be controlled<br /> remotely or within the body. Its miniature dimensions are expected<br /> to allow it to navigate and crawl in different natural spaces<br /> within the human body, including blood vessels, the digestive tract<br /> and the respiratory system as well as artificial spaces such as<br /> shunts, catheters, ports, etc. Its unique structure is expected to<br /> give it the ability to move in tight spaces and curved passages as<br /> well as the ability to remain within the human body for prolonged<br /> time. The SCS product was developed using the ViRob<br /> technology.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><i>TipCAT</i></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> TipCAT is a disposable self-propelled locomotive device that is<br /> specially designed to advance in tubular anatomies. The TipCAT is a<br /> mechanism comprising a series of interconnected balloons at the<br /> device’s tip that provides the TipCAT with its forward locomotion<br /> capability. The device can self-propel within natural tubular<br /> lumens such as the blood vessels, respiratory and the urinary and<br /> GI tracts. A single channel of air/fluid supply sequentially<br /> inflates and deflates a series of balloons creating an inchworm<br /> like forward motion. The TipCAT maintains a standard working<br /> channel for treatments. Unlike standard access devices such as<br /> guidewires, catheters for vascular access and endoscopes, the<br /> TipCAT does not need to be pushed into the patient’s lumen using<br /> external pressure; rather, it will gently advance itself through<br /> the organ’s anatomy. As a result, the TipCAT is designed to be able<br /> to reach every part of the lumen under examination regardless of<br /> the topography, be less operator dependent, and greatly reduce the<br /> likelihood of damage to lumen structure. The TipCAT thus offers<br /> functionality features equivalent to modern tubular access devices,<br /> along with advantages associated with its physiologically adapted<br /> self-propelling mechanism, flexibility, and design.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 4; OPTIONS: NEWSECTION --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><i>CardioSert</i></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>On<br /> May 25, 2018, Microbot acquired a patent-protected technology from<br /> CardioSert Ltd., a privately-held medical device company based in<br /> Israel that was part of a technological incubator supported by the<br /> Israel Innovation Authorities. The CardioSert technology<br /> contemplates a combination of a guidewire and microcatheter,<br /> technologies that are broadly used for surgery within a tubular<br /> organ or structure such as a blood vessel or duct. The CardioSert<br /> technology features a unique guidewire delivery system with<br /> steering and stiffness control capabilities which when developed is<br /> expected to give the physician the ability to control the tip<br /> curvature, to adjust tip load to varying degrees of stiffness in a<br /> gradually continuous manner. The CardioSert technology was<br /> originally developed to support interventional cardiologists in<br /> crossing chronic total occlusions (CTO) during percutaneous<br /> coronary intervention (PCI) procedures and has the potential to be<br /> used in other spaces and applications, such as peripheral<br /> intervention, and neurosurgery.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><i>Liberty</i></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>On<br /> January 13, 2020, Microbot unveiled what it believes is the world’s<br /> first fully disposable robotic system for use in Endovascular<br /> Interventional procedures, such as cardiovascular, peripheral and<br /> neurovascular. The Liberty robotic system features a unique compact<br /> design with the capability to be operated remotely, reduce<br /> radiation exposure and physical strain to the physician, as well as<br /> the potential to eliminate the use of multiple consumables through<br /> its “One & Done” capabilities, based in part on the CardioSert<br /> platform.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>Liberty<br /> is designed to maneuver guidewires and over-the-wire devices (such<br /> as microcatheters) within the body’s vasculature. It eliminates the<br /> need for extensive capital equipment requiring dedicated Cath-lab<br /> rooms as well as dedicated staff. In addition, it is being designed<br /> to streamline Cath-lab procedures with our proprietary “One &<br /> Done” tool that combines guidewire and microcatheter into a single<br /> device. With control over tip curvature and stiffness for<br /> maneuverability and access – and without the need for constant tool<br /> exchanges – the “One & Done” feature of Liberty may drastically<br /> reduce procedure time and costs while enhancing the operator<br /> experience.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>On<br /> August 17, 2020, Microbot announced the successful conclusion of<br /> its feasibility animal study using the Liberty robotic system. The<br /> study met all of its end points with no intraoperative adverse<br /> events, which supports Microbot’s objectives to allow physicians to<br /> conduct a catheter-based procedure from outside the catheterization<br /> laboratory (cath-lab), avoiding radiation exposure, physical strain<br /> and the risk of cross contamination. The study was performed by two<br /> leading physicians in the neuro vascular and peripheral vascular<br /> intervention spaces, and the results demonstrated robust navigation<br /> capabilities, intuitive usability and accurate deployment of<br /> embolic agents, most of which was conducted remotely from the<br /> cath-lab’s control room.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>We<br /> are continuously exploring and evaluating additional innovative<br /> guidewire/microcatheter technologies to be integrated and combined<br /> with the Liberty robotic platform.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Additional<br /> Information</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>For<br /> additional information related to our business and operations,<br /> please refer to the reports incorporated herein by reference,<br /> including our Annual Report on Form 10-K for the year ended<br /> December 31, 2019 as described under the caption “Incorporation of<br /> Documents by Reference” on page 23 of this prospectus.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><b>Our<br /> Corporate Information</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>Our<br /> Company was incorporated on August 2, 1988 in the State of Delaware<br /> under the name Cellular Transplants, Inc. The original Certificate<br /> of Incorporation was restated on February 14, 1992 to change the<br /> name of the Company to CytoTheraputics, Inc. On May 24, 2000, the<br /> Certificate of Incorporation as restated was further amended to<br /> change the name of the Company to StemCells, Inc. On November 28,<br /> 2016, C&RD Israel Ltd., a wholly-owned subsidiary of the<br /> Company, completed its merger with and into Microbot Medical Ltd.,<br /> an Israeli corporation, with Microbot Israel Ltd. surviving as a<br /> wholly-owned subsidiary of the Company, or the Merger. Prior to the<br /> Merger, the Company was a biopharmaceutical company that operated<br /> in one segment: the research, development, and commercialization of<br /> stem cell therapeutics and related technologies. Immediately<br /> following the closing of the Merger, the business of Microbot<br /> Medical Ltd. became our sole focus. In connection with the Merger,<br /> we also changed our name from StemCells, Inc. to Microbot Medical<br /> Inc. On November 29, 2016, the stock of the Company began trading<br /> on the Nasdaq Capital Market under the symbol “MBOT”.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 5 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> principal executive offices are located at 25 Recreation Park<br /> Drive, Unit 108, Hingham, Massachusetts 02043. Microbot also has an<br /> executive office at 6 Hayozma Street, Yoqneam, P.O.B. 242, Israel<br /> 2069204. Our telephone number is (781) 875-3605. We maintain an<br /> Internet website at www.microbotmedical.com. The information<br /> contained on, connected to or that can be accessed via our website<br /> is not part of this prospectus. We have included our website<br /> address in this prospectus as an inactive textual reference only<br /> and not as an active hyperlink.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q,<br /> Current Reports on Form 8-K and all amendments to those reports<br /> filed or furnished pursuant to Section 13(a) or 15(d) of the<br /> Securities Exchange Act of 1934, as amended, or the Exchange Act,<br /> are available free of charge through the investor relations page of<br /> our internet website as soon as reasonably practicable after we<br /> electronically file such material with, or furnish it to, the<br /> SEC.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Offerings<br /> Under This Prospectus</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Under<br /> this prospectus, we may offer shares of our common stock or<br /> preferred stock, various series of debt securities and/or warrants<br /> or rights to purchase any such securities, either individually or<br /> in units, with a total value of up to $75,000,000, from time to<br /> time at prices and on terms to be determined by market conditions<br /> at the time of the offering. This prospectus provides you with a<br /> general description of the securities we may offer. Each time we<br /> offer a type or series of securities under this prospectus, we will<br /> provide a prospectus supplement that will describe the specific<br /> amounts, prices and other important terms of the securities,<br /> including, to the extent applicable:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>designation<br /> or classification;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>aggregate<br /> principal amount or aggregate offering price;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>maturity,<br /> if applicable;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>rates<br /> and times of payment of interest or dividends, if any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>redemption<br /> or conversion terms, if any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>voting<br /> or other rights, if any; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>conversion<br /> or exercise prices, if any.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> prospectus supplement also may add, update or change information<br /> contained in this prospectus or in documents we have incorporated<br /> by reference into this prospectus. However, no prospectus<br /> supplement will fundamentally change the terms that are set forth<br /> in this prospectus or offer a security that is not registered and<br /> described in this prospectus at the time of its<br /> effectiveness.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> may sell the securities directly to investors or to or through<br /> agents, underwriters or dealers. We, and our agents or<br /> underwriters, reserve the right to accept or reject all or part of<br /> any proposed purchase of securities. If we offer securities through<br /> agents or underwriters, we will include in the applicable<br /> prospectus supplement:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>the<br /> names of those agents or underwriters;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>applicable<br /> fees, discounts and commissions to be paid to them;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>details<br /> regarding over-allotment options, if any; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>the<br /> net proceeds to us.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>THIS<br /> PROSPECTUS MAY NOT BE USED TO CONSUMMATE A SALE OF ANY SECURITIES<br /> UNLESS IT IS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 6 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>RISK FACTORS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span><i>Investing<br /> in our securities involves significant risk. The prospectus<br /> supplement applicable to each offering of our securities may<br /> contain a discussion of the risks applicable to an investment in<br /> Microbot. Prior to making a decision about investing in our<br /> securities, you should consider the “Risk Factors” included and<br /> incorporated by reference in this prospectus and any applicable<br /> prospectus supplement, including the risk factors incorporated by<br /> reference from our most recent Annual Report on Form 10-K, as<br /> updated by our Quarterly Reports on Form 10-Q and our other filings<br /> with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the<br /> Exchange Act filed after such annual report. The risks and<br /> uncertainties we describe are not the only ones facing us.<br /> Additional risks not presently known to us, or that we currently<br /> deem immaterial, may also impair our business operations. If any of<br /> these risks were to occur, our business, financial condition, or<br /> results of operations would likely suffer. In that event, the<br /> trading price of our common stock could decline, and you could lose<br /> all or part of your investment.</i></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span><i> </i></span></p> <p><!-- FIELD: PAGE; SEQUENCE: 7 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><i> </i></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>SPECIAL NOTE REGARDING FORWARD-LOOKING<br /> STATEMENTS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>This<br /> prospectus and the documents incorporated by reference in this<br /> prospectus include forward-looking statements within the meaning of<br /> Section 27A of the Securities Act of 1933, as amended, or the<br /> Securities Act, and Section 21E of the Exchange Act that relate to<br /> future events or our future operations or financial performance and<br /> involve known and unknown risks, uncertainties and other factors<br /> that may cause our actual results, levels of activity, performance<br /> or achievements to differ materially from any future results,<br /> levels of activity, performance or achievements expressed or<br /> implied by these forward-looking statements. In some cases, you can<br /> identify forward-looking statements by terminology such as “may”,<br /> “should”, “intends”, “expects”, “plans”, “targets”, “anticipates”,<br /> “believes”, “estimates”, “will”, “would”, “predicts”, “potential”,<br /> or “continue” or the negative of these terms or other comparable<br /> terminology. These statements are only predictions and involve<br /> known and unknown risks, uncertainties and other factors. The<br /> Private Securities Litigation Reform Act of 1995 provides a “safe<br /> harbor” for such forward-looking statements. In order to comply<br /> with the terms of the safe harbor, we note that a variety of<br /> factors could cause actual results and experience to differ<br /> materially from the anticipated results or other expectations<br /> expressed in the forward-looking statements.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>Such<br /> statements include, without limitation, all statements as to<br /> expectation or belief and statements as to our future results of<br /> operations; the progress of our research, product development and<br /> clinical programs; the need for, and timing of, additional capital<br /> and capital expenditures; partnering prospects; costs of<br /> manufacturing products; the protection of, and the need for,<br /> additional intellectual property rights; effects of regulations;<br /> the need for additional facilities; and potential market<br /> opportunities. Our actual results may vary materially from those<br /> contained in such forward-looking statements because of risks to<br /> which we are subject, including the fact that additional trials<br /> will be required to confirm the safety and demonstrate the efficacy<br /> of our planned products; uncertainty as to whether the U.S. Food<br /> and Drug Administration, or the FDA, or other regulatory<br /> authorities will clear our proposed products for commercialization<br /> and sale; the risk that our planned clinical trials or studies<br /> could be substantially delayed beyond their expected dates or cause<br /> us to incur substantial unanticipated costs; uncertainties in our<br /> ability to obtain the capital resources needed to continue our<br /> current research and development operations and to conduct the<br /> research, preclinical development and clinical trials necessary for<br /> regulatory approvals; the uncertainty regarding the outcome of our<br /> clinical trials or studies we may conduct in the future; the<br /> uncertainty regarding the validity and enforceability of the<br /> patents underlying our proposed products; the uncertainty as to<br /> whether the Company’s preclinical studies will be replicated in<br /> humans; the uncertainty whether any of our proposed products will<br /> prove clinically safe and effective; the uncertainty of whether we<br /> will achieve significant revenue from product sales or become<br /> profitable; obsolescence of our technologies; competition from<br /> third parties; intellectual property rights of third parties;<br /> litigation risks; legal and regulatory developments in Israel; and<br /> other risks to which we are subject.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> have based these forward-looking statements on our current<br /> expectations and projections about future events. We believe that<br /> the assumptions and expectations reflected in such forward-looking<br /> statements are reasonable, based on information available to us on<br /> the date hereof, but we cannot assure you that these assumptions<br /> and expectations will prove to have been correct or that we will<br /> take any action that we may presently be planning. These<br /> forward-looking statements are inherently subject to known and<br /> unknown risks and uncertainties. We have included important<br /> cautionary statements in this prospectus, in the documents<br /> incorporated by reference in this prospectus, and in the sections<br /> in our periodic reports, including our most recent Annual Report on<br /> Form 10-K, entitled “Business,” “Risk Factors,” and “Management’s<br /> Discussion and Analysis of Financial Condition and Results of<br /> Operations,” as supplemented by our subsequent Quarterly Reports on<br /> Form 10-Q or our Current Reports on Form 8-K, discussing some of<br /> the factors that we believe could cause actual results or events to<br /> differ materially from the forward-looking statements that we are<br /> making including, but are not limited to, research and product<br /> development uncertainties, regulatory policies and approval<br /> requirements, competition from other similar businesses, market and<br /> general economic factors.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>In<br /> light of these assumptions, risks and uncertainties, the results<br /> and events discussed in the forward-looking statements contained in<br /> this prospectus or in any document incorporated herein by reference<br /> might not occur. Investors are cautioned not to place undue<br /> reliance on the forward-looking statements, which speak only as of<br /> the date of this prospectus or the date of the document<br /> incorporated by reference in this prospectus. We are not under any<br /> obligation, and we expressly disclaim any obligation, to update or<br /> alter any forward-looking statements, whether as a result of new<br /> information, future events or otherwise. All subsequent<br /> forward-looking statements attributable to us or to any person<br /> acting on our behalf are expressly qualified in their entirety by<br /> the cautionary statements contained or referred to in this<br /> section.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 8 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span><b>USE OF PROCEEDS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> cannot assure you that we will receive any proceeds in connection<br /> with securities which may be offered pursuant to this prospectus.<br /> Unless otherwise indicated in the applicable prospectus supplement,<br /> we intend to use any net proceeds from the sale of securities under<br /> this prospectus for our operations, our further development and<br /> commercialization of our product candidates, other general<br /> corporate purposes, which may include, but are not limited to,<br /> working capital, intellectual property protection and enforcement,<br /> capital expenditures, repayment of indebtedness and collaborations,<br /> and the costs of acquiring, licensing or investing in new and<br /> existing businesses, product candidates and technologies. We have<br /> not determined the amounts we plan to spend on any of the areas<br /> listed above or the timing of these expenditures. As a result, our<br /> management will have broad discretion to allocate the net proceeds,<br /> if any, we receive in connection with securities offered pursuant<br /> to this prospectus for any purpose. Pending application of the net<br /> proceeds as described above, we may initially invest the net<br /> proceeds in short-term, investment-grade or interest-bearing<br /> securities in accordance with our cash-management policies.<br /> Additional information on the use of proceeds from the sale of<br /> securities offered by this prospectus may be set forth in the<br /> prospectus supplement relating to that offering.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 9 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>PLAN OF DISTRIBUTION</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>We<br /> may offer securities under this prospectus from time to time<br /> pursuant to public offerings through one or more placement agents<br /> or underwriters, negotiated transactions, block trades or a<br /> combination of these methods. We may sell the securities (1)<br /> through underwriters or dealers, (2) through agents or (3) directly<br /> to one or more purchasers, or through a combination of such<br /> methods. We may distribute the securities from time to time in one<br /> or more transactions at:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>a<br /> fixed price or prices, which may be changed from time to<br /> time;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>market<br /> prices prevailing at the time of sale;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>prices<br /> related to the prevailing market prices; or</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>negotiated<br /> prices.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 13.5PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>We<br /> may directly solicit offers to purchase the securities being<br /> offered by this prospectus. We may also designate agents to solicit<br /> offers to purchase the securities from time to time, and may enter<br /> into arrangements for “at the market,” equity line or similar<br /> transactions. We will name in a prospectus supplement any<br /> underwriter or agent involved in the offer or sale of the<br /> securities.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 13.5PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>If we<br /> utilize a dealer in the sale of the securities being offered by<br /> this prospectus, we will sell the securities to the dealer, as<br /> principal. The dealer may then resell the securities to the public<br /> at varying prices to be determined by the dealer at the time of<br /> resale.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>If we<br /> utilize an underwriter in the sale of the securities being offered<br /> by this prospectus, we will execute an underwriting agreement with<br /> the underwriter at the time of sale, and we will provide the name<br /> of any underwriter in the prospectus supplement which the<br /> underwriter will use to make resales of the securities to the<br /> public. In connection with the sale of the securities, we, or the<br /> purchasers of the securities for whom the underwriter may act as<br /> agent, may compensate the underwriter in the form of underwriting<br /> discounts or commissions. The underwriter may sell the securities<br /> to or through dealers, and the underwriter may compensate those<br /> dealers in the form of discounts, concessions or<br /> commissions.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>With<br /> respect to underwritten public offerings, negotiated transactions<br /> and block trades, we will provide in the applicable prospectus<br /> supplement information regarding any compensation we pay to<br /> underwriters, dealers or agents in connection with the offering of<br /> the securities, and any discounts, concessions or commissions<br /> allowed by underwriters to participating dealers. Underwriters,<br /> dealers and agents participating in the distribution of the<br /> securities may be deemed to be underwriters within the meaning of<br /> the Securities Act, and any discounts and commissions received by<br /> them and any profit realized by them on resale of the securities<br /> may be deemed to be underwriting discounts and commissions. We may<br /> enter into agreements to indemnify underwriters, dealers and agents<br /> against civil liabilities, including liabilities under the<br /> Securities Act, or to contribute to payments they may be required<br /> to make in respect thereof.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>If so<br /> indicated in the applicable prospectus supplement, we will<br /> authorize underwriters, dealers or other persons acting as our<br /> agents to solicit offers by certain institutions to purchase<br /> securities from us pursuant to delayed delivery contracts providing<br /> for payment and delivery on the date stated in each applicable<br /> prospectus supplement. Each contract will be for an amount not less<br /> than, and the aggregate amount of securities sold pursuant to such<br /> contracts shall not be less nor more than, the respective amounts<br /> stated in each applicable prospectus supplement. Institutions with<br /> whom the contracts, when authorized, may be made include commercial<br /> and savings banks, insurance companies, pension funds, investment<br /> companies, educational and charitable institutions and other<br /> institutions, but shall in all cases be subject to our approval.<br /> Delayed delivery contracts will not be subject to any conditions<br /> except that:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> purchase by an institution of the securities covered under that<br /> contract shall not at the time of delivery be prohibited under the<br /> laws of the jurisdiction to which that institution is subject;<br /> and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if<br /> the securities are also being sold to underwriters acting as<br /> principals for their own account, the underwriters shall have<br /> purchased such securities not sold for delayed delivery. The<br /> underwriters and other persons acting as our agents will not have<br /> any responsibility in respect of the validity or performance of<br /> delayed delivery contracts.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 10 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>One<br /> or more firms, referred to as “remarketing firms,” may also offer<br /> or sell the securities, if a prospectus supplement so indicates, in<br /> connection with a remarketing arrangement upon their purchase.<br /> Remarketing firms will act as principals for their own accounts or<br /> as our agents. These remarketing firms will offer or sell the<br /> securities in accordance with the terms of the securities. Each<br /> prospectus supplement will identify and describe any remarketing<br /> firm and the terms of its agreement, if any, with us and will<br /> describe the remarketing firm’s compensation. Remarketing firms may<br /> be deemed to be underwriters in connection with the securities they<br /> remarket. Remarketing firms may be entitled under agreements that<br /> may be entered into with us to indemnification by us against<br /> certain civil liabilities, including liabilities under the<br /> Securities Act, and may be customers of, engage in transactions<br /> with or perform services for us in the ordinary course of<br /> business.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>Certain<br /> underwriters may use this prospectus and any accompanying<br /> prospectus supplement for offers and sales related to market-making<br /> transactions in the securities. These underwriters may act as<br /> principal or agent in these transactions, and the sales will be<br /> made at prices related to prevailing market prices at the time of<br /> sale. Any underwriters involved in the sale of the securities may<br /> qualify as “underwriters” within the meaning of Section 2(a)(11) of<br /> the Securities Act. In addition, the underwriters’ commissions,<br /> discounts or concessions may qualify as underwriters’ compensation<br /> under the Securities Act and the rules of the Financial Industry<br /> Regulatory Authority, Inc., or FINRA.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>Shares<br /> of our common stock sold pursuant to the registration statement of<br /> which this prospectus is a part will be authorized for listing and<br /> trading on The Nasdaq Capital Market. The applicable prospectus<br /> supplement will contain information, where applicable, as to any<br /> other listing, if any, on The Nasdaq Capital Market or any<br /> securities market or other securities exchange of the securities<br /> covered by the prospectus supplement. Underwriters may make a<br /> market in our common stock, but will not be obligated to do so and<br /> may discontinue any market making at any time without notice. We<br /> can make no assurance as to the liquidity of or the existence,<br /> development or maintenance of trading markets for any of the<br /> securities.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>In<br /> order to facilitate the offering of the securities, certain persons<br /> participating in the offering may engage in transactions that<br /> stabilize, maintain or otherwise affect the price of the<br /> securities. This may include over-allotments or short sales of the<br /> securities, which involve the sale by persons participating in the<br /> offering of more securities than we sold to them. In these<br /> circumstances, these persons would cover such over-allotments or<br /> short positions by making purchases in the open market or by<br /> exercising their over-allotment option. In addition, these persons<br /> may stabilize or maintain the price of the securities by bidding<br /> for or purchasing the applicable security in the open market or by<br /> imposing penalty bids, whereby selling concessions allowed to<br /> dealers participating in the offering may be reclaimed if the<br /> securities sold by them are repurchased in connection with<br /> stabilization transactions. The effect of these transactions may be<br /> to stabilize or maintain the market price of the securities at a<br /> level above that which might otherwise prevail in the open market.<br /> These transactions may be discontinued at any time.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>The<br /> underwriters, dealers and agents may engage in other transactions<br /> with us, or perform other services for us, in the ordinary course<br /> of their business.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>.</span></p> <p><!-- FIELD: PAGE; SEQUENCE: 11 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span><b>DESCRIPTION OF COMMON<br /> STOCK</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> are authorized to issue 60,000,000 shares of common stock, par<br /> value $0.01 per share. As of September 30, 2020 we had 7,108,133<br /> shares of common stock issued and outstanding and approximately 139<br /> common stockholders of record. The following summary of certain<br /> provisions of our common stock does not purport to be complete. You<br /> should refer to our certificate of incorporation and our bylaws,<br /> <span>copies of which are on file<br /> with the SEC as exhibits to previous SEC filings</span>.<br /> <span>Please refer to “Where You<br /> Can Find More Information” below for directions on obtaining these<br /> documents.</span> The summary below is also qualified by provisions<br /> of applicable law.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>General</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Holders<br /> of common stock are entitled to one vote for each share held on all<br /> matters submitted to a vote of stockholders and do not have<br /> cumulative voting rights. Holders of common stock are entitled to<br /> receive proportionately any dividends as may be declared by our<br /> board of directors, out of funds that we may legally use to pay<br /> dividends, subject to any preferential dividend rights of any<br /> outstanding series of preferred stock or series of preferred stock<br /> that we may designate and issue in the future. All shares of common<br /> stock outstanding as of the date of this prospectus and, upon<br /> issuance and sale, all shares of common stock that we may offer<br /> pursuant to this prospectus, will be fully paid and<br /> nonassessable.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>In<br /> the event of our liquidation or dissolution, the holders of common<br /> stock are entitled to receive proportionately our net assets<br /> available for distribution to stockholders after the payment of all<br /> debts and other liabilities and subject to the prior rights of any<br /> outstanding preferred stock. Holders of common stock have no<br /> preemptive, subscription, redemption or conversion rights. There<br /> are no redemption or sinking fund provisions applicable to the<br /> common stock.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><b>Transfer<br /> Agent and Registrar</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>The<br /> transfer agent and registrar for our common stock is Computershare<br /> Trust Company, N.A.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><b>Nasdaq<br /> Capital Market</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>Our<br /> common stock is listed for quotation on the Nasdaq Capital Market<br /> under the symbol “MBOT.”</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 12 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>DESCRIPTION OF PREFERRED<br /> STOCK</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> have authority to issue 1,000,000 shares of preferred stock, par<br /> value $0.01 per share. As of the date of this prospectus, no shares<br /> of our preferred stock were outstanding or designated.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> following summary of certain provisions of our preferred stock does<br /> not purport to be complete. You should refer to our certificate of<br /> incorporation and by-laws, as amended to date, <span>copies of which are on file with the SEC<br /> as exhibits to previous SEC filings. Please refer to “Where You Can<br /> Find More Information” below for directions on obtaining these<br /> documents.</span> The summary below is also qualified by provisions<br /> of applicable law.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> board of directors is authorized, without stockholder approval,<br /> from time to time, to issue shares of preferred stock in series and<br /> may, at the time of issuance, subject to Delaware law and our<br /> certificate of incorporation and by-laws, determine the rights,<br /> preferences and limitations of each series, including voting<br /> rights, dividend rights and redemption and liquidation preferences.<br /> Satisfaction of any dividend preferences of outstanding shares of<br /> preferred stock would reduce the amount of funds available for the<br /> payment of dividends on shares of our common stock. Holders of<br /> shares of preferred stock may be entitled to receive a preference<br /> payment in the event of any liquidation, dissolution or winding-up<br /> of our company before any payment is made to the holders of shares<br /> of our common stock. In some circumstances, the issuance of shares<br /> of preferred stock may render more difficult or tend to discourage<br /> a merger, tender offer or proxy contest, the assumption of control<br /> by a holder of a large block of our securities or the removal of<br /> incumbent management. Upon the affirmative vote of our board of<br /> directors, without stockholder approval, we may issue shares of<br /> preferred stock with voting and conversion rights which could<br /> adversely affect the holders of shares of our common<br /> stock.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>If we<br /> offer a specific series of preferred stock under this prospectus,<br /> we will describe the terms of the preferred stock in the prospectus<br /> supplement for such offering and will file a copy of the<br /> certificate establishing the terms of the preferred stock with the<br /> SEC. To the extent required, this description will<br /> include:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> title and stated value;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> number of shares offered, the liquidation preference per share and<br /> the purchase price;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> dividend rate(s), period(s) and/or payment date(s), or method(s) of<br /> calculation for such dividends;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> dividends will be cumulative or non-cumulative and, if cumulative,<br /> the date from which dividends will accumulate;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> procedures for any auction and remarketing, if any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> provisions for a sinking fund, if any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> provisions for redemption, if applicable;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> listing of the preferred stock on any securities exchange or<br /> market;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> the preferred stock will be convertible into our common stock, and,<br /> if applicable, the conversion price (or how it will be calculated)<br /> and conversion period;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> the preferred stock will be exchangeable into debt securities, and,<br /> if applicable, the exchange price (or how it will be calculated)<br /> and exchange period;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>voting<br /> rights, if any, of the preferred stock;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>a<br /> discussion of any material and/or special U.S. federal income tax<br /> considerations applicable to the preferred stock;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> relative ranking and preferences of the preferred stock as to<br /> dividend rights and rights upon liquidation, dissolution or winding<br /> up of the affairs of the Company; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> material limitations on issuance of any class or series of<br /> preferred stock ranking senior to or on a parity with the series of<br /> preferred stock as to dividend rights and rights upon liquidation,<br /> dissolution or winding up of the Company.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> preferred stock offered by this prospectus will, when issued, be<br /> fully paid and nonassessable and will not have, or be subject to,<br /> any preemptive or similar rights.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><b>Transfer<br /> Agent and Registrar</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>The<br /> transfer agent and registrar for any series or class of preferred<br /> stock will be set forth in the applicable prospectus<br /> supplement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 13 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span><b>DESCRIPTION OF WARRANTS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>We<br /> may issue warrants to purchase shares of our common stock,<br /> preferred stock and/or debt securities in one or more series<br /> together with other securities or separately, as described in the<br /> applicable prospectus supplement. Below is a description of certain<br /> general terms and provisions of the warrants that we may offer.<br /> Particular terms of the warrants will be described in the warrant<br /> agreements and the prospectus supplement to the<br /> warrants.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span>The<br /> applicable prospectus supplement will contain, where applicable,<br /> the following terms of, and other information relating to, the<br /> warrants:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> specific designation and aggregate number of, and the price at<br /> which we will issue, the warrants;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> currency or currency units in which the offering price, if any, and<br /> the exercise price are payable;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> designation, amount and terms of the securities purchasable upon<br /> exercise of the warrants;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if<br /> applicable, the exercise price for shares of our common stock and<br /> the number of shares of common stock to be received upon exercise<br /> of the warrants;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if<br /> applicable, the exercise price for shares of our preferred stock,<br /> the number of shares of preferred stock to be received upon<br /> exercise, and a description of that series of our preferred<br /> stock;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if<br /> applicable, the exercise price for our debt securities, the amount<br /> of debt securities to be received upon exercise, and a description<br /> of that series of debt securities;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> date on which the right to exercise the warrants will begin and the<br /> date on which that right will expire or, if you may not<br /> continuously exercise the warrants throughout that period, the<br /> specific date or dates on which you may exercise the<br /> warrants;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> the warrants will be issued in fully registered form or bearer<br /> form, in definitive or global form or in any combination of these<br /> forms, although, in any case, the form of a warrant included in a<br /> unit will correspond to the form of the unit and of any security<br /> included in that unit;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> applicable material U.S. federal income tax<br /> consequences;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> identity of the warrant agent for the warrants and of any other<br /> depositaries, execution or paying agents, transfer agents,<br /> registrars or other agents;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> proposed listing, if any, of the warrants or any securities<br /> purchasable upon exercise of the warrants on any securities<br /> exchange;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if<br /> applicable, the date from and after which the warrants and the<br /> common stock, preferred stock and/or debt securities will be<br /> separately transferable;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if<br /> applicable, the minimum or maximum amount of the warrants that may<br /> be exercised at any one time;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>information<br /> with respect to book-entry procedures, if any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> anti-dilution provisions of the warrants, if any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> redemption or call provisions;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> the warrants are to be sold separately or with other securities as<br /> parts of units; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> additional terms of the warrants, including terms, procedures and<br /> limitations relating to the exchange and exercise of the<br /> warrants.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 14 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Outstanding<br /> Warrants</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>As of<br /> September 30, 2020, we had outstanding:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>warrants<br /> to purchase 183 shares of our common stock at an exercise price of<br /> $2,754.00 per share, which are exercisable through April 9,<br /> 2023;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>warrants<br /> to purchase 2,770 shares of our common stock at an exercise price<br /> of $40.50 per share, which are exercisable through March 14,<br /> 2022;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>warrants<br /> to purchase 8,082 shares of our common stock at an exercise price<br /> of $8.13 per share, which are exercisable through July 14,<br /> 2022;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>warrants<br /> to purchase 29,500 shares of our common stock at an exercise price<br /> of $12.50 per share, which are exercisable through July 15,<br /> 2022;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>warrants<br /> to purchase 45,643 shares of our common stock at an exercise price<br /> of $13.13 per share, which are exercisable through June 25,<br /> 2023;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>warrants<br /> to purchase 47,619 shares of our common stock at an exercise price<br /> of $13.13 per share, which are exercisable through June 27, 2023;<br /> and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>warrants<br /> to purchase 45,045 shares of our common stock at an exercise price<br /> of $13.88 per share, which are exercisable through June 30,<br /> 2023.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span><b>Transfer<br /> Agent and Registrar</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT; BACKGROUND-COLOR: WHITE"> <span>The<br /> transfer agent and registrar for any warrants will be set forth in<br /> the applicable prospectus supplement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 15 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span><b>DESCRIPTION OF DEBT<br /> SECURITIES</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> following description, together with the additional information we<br /> include in any applicable prospectus supplements, summarizes the<br /> material terms and provisions of the debt securities that we may<br /> offer under this prospectus. While the terms we have summarized<br /> below will apply generally to any future debt securities we may<br /> offer pursuant to this prospectus, we will describe the particular<br /> terms of any debt securities that we may offer in more detail in<br /> the applicable prospectus supplement. If we so indicate in a<br /> prospectus supplement, the terms of any debt securities offered<br /> under such prospectus supplement may differ from the terms we<br /> describe below, and to the extent the terms set forth in a<br /> prospectus supplement differ from the terms described below, the<br /> terms set forth in the prospectus supplement shall<br /> control.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> may sell from time to time, in one or more offerings under this<br /> prospectus, debt securities, which may be senior or subordinated.<br /> We will issue any such senior debt securities under a senior<br /> indenture that we will enter into with a trustee to be named in the<br /> senior indenture. We will issue any such subordinated debt<br /> securities under a subordinated indenture, which we will enter into<br /> with a trustee to be named in the subordinated indenture. We have<br /> filed forms of these documents as exhibits to the registration<br /> statement, of which this prospectus is a part. We use the term<br /> “indentures” to refer to either the senior indenture or the<br /> subordinated indenture, as applicable. The indentures will be<br /> qualified under the Trust Indenture Act of 1939, or the Trust<br /> Indenture Act, as in effect on the date of the indenture. We use<br /> the term “debenture trustee” to refer to either the trustee under<br /> the senior indenture or the trustee under the subordinated<br /> indenture, as applicable.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> following summaries of material provisions of the senior debt<br /> securities, the subordinated debt securities and the indentures are<br /> subject to, and qualified in their entirety by reference to, all<br /> the provisions of the indenture applicable to a particular series<br /> of debt securities.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>General</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Each<br /> indenture provides that debt securities may be issued from time to<br /> time in one or more series and may be denominated and payable in<br /> foreign currencies or units based on or relating to foreign<br /> currencies. Neither the senior indenture nor any subordinated<br /> indenture limits the amount of debt securities that may be issued<br /> thereunder, and each indenture provides that the specific terms of<br /> any series of debt securities shall be set forth in, or determined<br /> pursuant to, an authorizing resolution and/or a supplemental<br /> indenture, if any, relating to such series.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>We<br /> will describe in each prospectus supplement the following terms<br /> relating to a series of debt securities:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> title or designation;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> aggregate principal amount and any limit on the amount that may be<br /> issued;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> currency or units based on or relating to currencies in which debt<br /> securities of such series are denominated and the currency or units<br /> in which principal or interest or both will or may be<br /> payable;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> we will issue the series of debt securities in global form, the<br /> terms of any global securities and who the depositary will<br /> be;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> maturity date and the date or dates on which principal will be<br /> payable;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> interest rate, which may be fixed or variable, or the method for<br /> determining the rate and the date interest will begin to accrue,<br /> the date or dates interest will be payable and the record dates for<br /> interest payment dates or the method for determining such<br /> dates;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> or not the debt securities will be secured or unsecured, and the<br /> terms of any secured debt;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> terms of the subordination of any series of subordinated<br /> debt;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> place or places where payments will be payable;</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 16 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>our<br /> right, if any, to defer payment of interest and the maximum length<br /> of any such deferral period;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> date, if any, after which, and the price at which, we may, at our<br /> option, redeem the series of debt securities pursuant to any<br /> optional redemption provisions;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> date, if any, on which, and the price at which we are obligated,<br /> pursuant to any mandatory sinking fund provisions or otherwise, to<br /> redeem, or at the holder’s option to purchase, the series of debt<br /> securities;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> the indenture will restrict our ability to pay dividends, or will<br /> require us to maintain any asset ratios or reserves;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> we will be restricted from incurring any additional<br /> indebtedness;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>a<br /> discussion on any material or special U.S. federal income tax<br /> considerations applicable to a series of debt<br /> securities;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> denominations in which we will issue the series of debt securities,<br /> if other than denominations of $1,000 and any integral multiple<br /> thereof; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> other specific terms, preferences, rights or limitations of, or<br /> restrictions on, the debt securities.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> may issue debt securities that provide for an amount less than<br /> their stated principal amount to be due and payable upon<br /> declaration of acceleration of their maturity pursuant to the terms<br /> of the indenture. We will provide you with information on the<br /> federal income tax considerations and other special considerations<br /> applicable to any of these debt securities in the applicable<br /> prospectus supplement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Conversion<br /> or Exchange Rights</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will set forth in the prospectus supplement the terms, if any, on<br /> which a series of debt securities may be convertible into or<br /> exchangeable for our common stock or our other securities. We will<br /> include provisions as to whether conversion or exchange is<br /> mandatory, at the option of the holder or at our option. We may<br /> include provisions pursuant to which the number of shares of our<br /> common stock or our other securities that the holders of the series<br /> of debt securities receive would be subject to<br /> adjustment.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Consolidation,<br /> Merger or Sale; No Protection in Event of a Change of Control or<br /> Highly Leveraged Transaction</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> indentures do not contain any covenant that restricts our ability<br /> to merge or consolidate, or sell, convey, transfer or otherwise<br /> dispose of all or substantially all of our assets. However, any<br /> successor to or acquirer of such assets must assume all of our<br /> obligations under the indentures or the debt securities, as<br /> appropriate.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Unless<br /> we state otherwise in the applicable prospectus supplement, the<br /> debt securities will not contain any provisions that may afford<br /> holders of the debt securities protection in the event we have a<br /> change of control or in the event of a highly leveraged transaction<br /> (whether or not such transaction results in a change of control),<br /> which could adversely affect holders of debt securities.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Events<br /> of Default Under the Indenture</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span>The<br /> following are events of default under the indentures with respect<br /> to any series of debt securities that we may issue:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if we<br /> fail to pay interest when due and our failure continues for 90 days<br /> and the time for payment has not been extended or<br /> deferred;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if we<br /> fail to pay the principal, or premium, if any, when due and the<br /> time for payment has not been extended or delayed;</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 17 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY; WIDTH: 0.25IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if we<br /> fail to observe or perform any other covenant set forth in the debt<br /> securities of such series or the applicable indentures, other than<br /> a covenant specifically relating to and for the benefit of holders<br /> of another series of debt securities, and our failure continues for<br /> 90 days after we receive written notice from the debenture trustee<br /> or holders of not less than a majority in aggregate principal<br /> amount of the outstanding debt securities of the applicable series;<br /> and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>if<br /> specified events of bankruptcy, insolvency or reorganization occur<br /> as to us.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>No<br /> event of default with respect to a particular series of debt<br /> securities (except as to certain events of bankruptcy, insolvency<br /> or reorganization) necessarily constitutes an event of default with<br /> respect to any other series of debt securities. The occurrence of<br /> an event of default may constitute an event of default under any<br /> bank credit agreements we may have in existence from time to time.<br /> In addition, the occurrence of certain events of default or<br /> acceleration under the indenture may constitute an event of default<br /> under certain of our other indebtedness outstanding from time to<br /> time.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>If an<br /> event of default with respect to debt securities of any series at<br /> the time outstanding occurs and is continuing, then the trustee or<br /> the holders of not less than a majority in principal amount of the<br /> outstanding debt securities of that series may, by a notice in<br /> writing to us (and to the debenture trustee if given by the<br /> holders), declare to be due and payable immediately the principal<br /> (or, if the debt securities of that series are discount securities,<br /> that portion of the principal amount as may be specified in the<br /> terms of that series) of and premium and accrued and unpaid<br /> interest, if any, on all debt securities of that series. Before a<br /> judgment or decree for payment of the money due has been obtained<br /> with respect to debt securities of any series, the holders of a<br /> majority in principal amount of the outstanding debt securities of<br /> that series (or, at a meeting of holders of such series at which a<br /> quorum is present, the holders of a majority in principal amount of<br /> the debt securities of such series represented at such meeting) may<br /> rescind and annul the acceleration if all events of default, other<br /> than the non-payment of accelerated principal, premium, if any, and<br /> interest, if any, with respect to debt securities of that series,<br /> have been cured or waived as provided in the applicable indenture<br /> (including payments or deposits in respect of principal, premium or<br /> interest that had become due other than as a result of such<br /> acceleration). We refer you to the prospectus supplement relating<br /> to any series of debt securities that are discount securities for<br /> the particular provisions relating to acceleration of a portion of<br /> the principal amount of such discount securities upon the<br /> occurrence of an event of default.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Subject<br /> to the terms of the indentures, if an event of default under an<br /> indenture shall occur and be continuing, the debenture trustee will<br /> be under no obligation to exercise any of its rights or powers<br /> under such indenture at the request or direction of any of the<br /> holders of the applicable series of debt securities, unless such<br /> holders have offered the debenture trustee reasonable indemnity.<br /> The holders of a majority in principal amount of the outstanding<br /> debt securities of any series will have the right to direct the<br /> time, method and place of conducting any proceeding for any remedy<br /> available to the debenture trustee, or exercising any trust or<br /> power conferred on the debenture trustee, with respect to the debt<br /> securities of that series, provided that:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> direction so given by the holder is not in conflict with any law or<br /> the applicable indenture; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>subject<br /> to its duties under the Trust Indenture Act, the debenture trustee<br /> need not take any action that might involve it in personal<br /> liability or might be unduly prejudicial to the holders not<br /> involved in the proceeding.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>A<br /> holder of the debt securities of any series will only have the<br /> right to institute a proceeding under the indentures or to appoint<br /> a receiver or trustee, or to seek other remedies if:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> holder previously has given written notice to the debenture trustee<br /> of a continuing event of default with respect to that<br /> series;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> holders of at least a majority in aggregate principal amount of the<br /> outstanding debt securities of that series have made written<br /> request, and such holders have offered reasonable indemnity to the<br /> debenture trustee to institute the proceeding as trustee;<br /> and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> debenture trustee does not institute the proceeding, and does not<br /> receive from the holders of a majority in aggregate principal<br /> amount of the outstanding debt securities of that series (or at a<br /> meeting of holders of such series at which a quorum is present, the<br /> holders of a majority in principal amount of the debt securities of<br /> such series represented at such meeting) other conflicting<br /> directions within 60 days after the notice, request and<br /> offer.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 18 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>These<br /> limitations do not apply to a suit instituted by a holder of debt<br /> securities if we default in the payment of the principal, premium,<br /> if any, or interest on, the debt securities.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will periodically file statements with the applicable debenture<br /> trustee regarding our compliance with specified covenants in the<br /> applicable indenture.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Modification<br /> of Indenture; Waiver</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> debenture trustee and we may change the applicable indenture<br /> without the consent of any holders with respect to specific<br /> matters, including:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>to<br /> fix any ambiguity, defect or inconsistency in the indenture;<br /> and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>to<br /> change anything that does not materially adversely affect the<br /> interests of any holder of debt securities of any series issued<br /> pursuant to such indenture.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>In<br /> addition, under the indentures, the rights of holders of a series<br /> of debt securities may be changed by us and the debenture trustee<br /> with the written consent of the holders of at least a majority in<br /> aggregate principal amount of the outstanding debt securities of<br /> each series (or, at a meeting of holders of such series at which a<br /> quorum is present, the holders of a majority in principal amount of<br /> the debt securities of such series represented at such meeting)<br /> that is affected. However, the debenture trustee and we may make<br /> the following changes only with the consent of each holder of any<br /> outstanding debt securities affected:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>extending<br /> the fixed maturity of the series of debt securities;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>reducing<br /> the principal amount, reducing the rate of or extending the time of<br /> payment of interest, or any premium payable upon the redemption of<br /> any debt securities;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>reducing<br /> the principal amount of discount securities payable upon<br /> acceleration of maturity;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>making<br /> the principal of or premium or interest on any debt security<br /> payable in currency other than that stated in the debt security;<br /> or</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>reducing<br /> the percentage of debt securities, the holders of which are<br /> required to consent to any amendment or waiver.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Except<br /> for certain specified provisions, the holders of at least a<br /> majority in principal amount of the outstanding debt securities of<br /> any series (or, at a meeting of holders of such series at which a<br /> quorum is present, the holders of a majority in principal amount of<br /> the debt securities of such series represented at such meeting) may<br /> on behalf of the holders of all debt securities of that series<br /> waive our compliance with provisions of the indenture. The holders<br /> of a majority in principal amount of the outstanding debt<br /> securities of any series may on behalf of the holders of all the<br /> debt securities of such series waive any past default under the<br /> indenture with respect to that series and its consequences, except<br /> a default in the payment of the principal of, premium or any<br /> interest on any debt security of that series or in respect of a<br /> covenant or provision, which cannot be modified or amended without<br /> the consent of the holder of each outstanding debt security of the<br /> series affected; provided, however, that the holders of a majority<br /> in principal amount of the outstanding debt securities of any<br /> series may rescind an acceleration and its consequences, including<br /> any related payment default that resulted from the<br /> acceleration.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 19 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Discharge</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Each<br /> indenture provides that we can elect to be discharged from our<br /> obligations with respect to one or more series of debt securities,<br /> except for obligations to:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>register<br /> the transfer or exchange of debt securities of the<br /> series;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>replace<br /> stolen, lost or mutilated debt securities of the<br /> series;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>maintain<br /> paying agencies;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>hold<br /> monies for payment in trust;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>compensate<br /> and indemnify the trustee; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>appoint<br /> any successor trustee.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>In<br /> order to exercise our rights to be discharged with respect to a<br /> series, we must deposit with the trustee money or government<br /> obligations sufficient to pay all the principal of, the premium, if<br /> any, and interest on, the debt securities of the series on the<br /> dates payments are due.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Form,<br /> Exchange, and Transfer</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will issue the debt securities of each series only in fully<br /> registered form without coupons and, unless we otherwise specify in<br /> the applicable prospectus supplement, in denominations of $1,000<br /> and any integral multiple thereof. The indentures provide that we<br /> may issue debt securities of a series in temporary or permanent<br /> global form and as book-entry securities that will be deposited<br /> with, or on behalf of, The Depository Trust Company or another<br /> depositary named by us and identified in a prospectus supplement<br /> with respect to that series.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>At<br /> the option of the holder, subject to the terms of the indentures<br /> and the limitations applicable to global securities described in<br /> the applicable prospectus supplement, the holder of the debt<br /> securities of any series can exchange the debt securities for other<br /> debt securities of the same series, in any authorized denomination<br /> and of like tenor and aggregate principal amount.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Subject<br /> to the terms of the indentures and the limitations applicable to<br /> global securities set forth in the applicable prospectus<br /> supplement, holders of the debt securities may present the debt<br /> securities for exchange or for registration of transfer, duly<br /> endorsed or with the form of transfer endorsed thereon duly<br /> executed if so required by us or the security registrar, at the<br /> office of the security registrar or at the office of any transfer<br /> agent designated by us for this purpose. Unless otherwise provided<br /> in the debt securities that the holder presents for transfer or<br /> exchange or in the applicable indenture, we will make no service<br /> charge for any registration of transfer or exchange, but we may<br /> require payment of any taxes or other governmental<br /> charges.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will name in the applicable prospectus supplement the security<br /> registrar, and any transfer agent in addition to the security<br /> registrar, that we initially designate for any debt securities. We<br /> may at any time designate additional transfer agents or rescind the<br /> designation of any transfer agent or approve a change in the office<br /> through which any transfer agent acts, except that we will be<br /> required to maintain a transfer agent in each place of payment for<br /> the debt securities of each series.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>If we<br /> elect to redeem the debt securities of any series, we will not be<br /> required to:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>issue,<br /> register the transfer of, or exchange any debt securities of that<br /> series during a period beginning at the opening of business 15 days<br /> before the day of mailing of a notice of redemption of any debt<br /> securities that may be selected for redemption and ending at the<br /> close of business on the day of the mailing; or</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>register<br /> the transfer of or exchange any debt securities so selected for<br /> redemption, in whole or in part, except the unredeemed portion of<br /> any debt securities we are redeeming in part.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 20 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Information<br /> Concerning the Debenture Trustee</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> debenture trustee, other than during the occurrence and continuance<br /> of an event of default under the applicable indenture, undertakes<br /> to perform only those duties as are specifically set forth in the<br /> applicable indenture. Upon an event of default under an indenture,<br /> the debenture trustee under such indenture must use the same degree<br /> of care as a prudent person would exercise or use in the conduct of<br /> his or her own affairs. Subject to this provision, the debenture<br /> trustee is under no obligation to exercise any of the powers given<br /> it by the indentures at the request of any holder of debt<br /> securities unless it is offered reasonable security and indemnity<br /> against the costs, expenses and liabilities that it might<br /> incur.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Payment<br /> and Paying Agents</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Unless<br /> we otherwise indicate in the applicable prospectus supplement, we<br /> will make payment of the interest on any debt securities on any<br /> interest payment date to the person in whose name the debt<br /> securities, or one or more predecessor securities, are registered<br /> at the close of business on the regular record date for the<br /> interest.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will pay principal of and any premium and interest on the debt<br /> securities of a particular series at the office of the paying<br /> agents designated by us, except that unless we otherwise indicate<br /> in the applicable prospectus supplement, we will make interest<br /> payments by check which we will mail to the holder. Unless we<br /> otherwise indicate in a prospectus supplement, we will designate<br /> the corporate trust office of the debenture trustee in the City of<br /> New York as our sole paying agent for payments with respect to debt<br /> securities of each series. We will name in the applicable<br /> prospectus supplement any other paying agents that we initially<br /> designate for the debt securities of a particular series. We will<br /> maintain a paying agent in each place of payment for the debt<br /> securities of a particular series.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>All<br /> money we pay to a paying agent or the debenture trustee for the<br /> payment of the principal of or any premium or interest on any debt<br /> securities which remains unclaimed at the end of two years after<br /> such principal, premium or interest has become due and payable will<br /> be repaid to us, and the holder of the security thereafter may look<br /> only to us for payment thereof.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Governing<br /> Law</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> indentures and the debt securities will be governed by and<br /> construed in accordance with the laws of the State of New York,<br /> except to the extent that the Trust Indenture Act is<br /> applicable.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Subordination<br /> of Subordinated Debt Securities</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> obligations pursuant to any subordinated debt securities will be<br /> unsecured and will be subordinate and junior in priority of payment<br /> to certain of our other indebtedness to the extent described in a<br /> prospectus supplement. The subordinated indenture does not limit<br /> the amount of senior indebtedness we may incur. It also does not<br /> limit us from issuing any other secured or unsecured<br /> debt.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 21 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>DESCRIPTION OF RIGHTS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>General</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> may issue rights to our stockholders to purchase shares of our<br /> common stock, preferred stock or the other securities described in<br /> this prospectus. We may offer rights separately or together with<br /> one or more additional rights, debt securities, preferred stock,<br /> common stock or warrants, or any combination of those securities in<br /> the form of units, as described in the applicable prospectus<br /> supplement. Each series of rights will be issued under a separate<br /> rights agreement to be entered into between us and a bank or trust<br /> company, as rights agent. The rights agent will act solely as our<br /> agent in connection with the certificates relating to the rights of<br /> the series of certificates and will not assume any obligation or<br /> relationship of agency or trust for or with any holders of rights<br /> certificates or beneficial owners of rights. The following<br /> description sets forth certain general terms and provisions of the<br /> rights to which any prospectus supplement may relate. The<br /> particular terms of the rights to which any prospectus supplement<br /> may relate and the extent, if any, to which the general provisions<br /> may apply to the rights so offered will be described in the<br /> applicable prospectus supplement. To the extent that any particular<br /> terms of the rights, rights agreement or rights certificates<br /> described in a prospectus supplement differ from any of the terms<br /> described below, then the terms described below will be deemed to<br /> have been superseded by that prospectus supplement. We encourage<br /> you to read the applicable rights agreement and rights certificate<br /> for additional information before you decide whether to purchase<br /> any of our rights.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will provide in a prospectus supplement the following terms of the<br /> rights being issued:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> date of determining the stockholders entitled to the rights<br /> distribution;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> aggregate number of shares of common stock, preferred stock or<br /> other securities purchasable upon exercise of the<br /> rights;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> exercise price;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> aggregate number of rights issued;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> the rights are transferrable and the date, if any, on and after<br /> which the rights may be separately transferred;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> date on which the right to exercise the rights will commence, and<br /> the date on which the right to exercise the rights will<br /> expire;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> method by which holders of rights will be entitled to<br /> exercise;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> conditions to the completion of the offering, if any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> withdrawal, termination and cancellation rights, if<br /> any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> there are any backstop or standby purchaser or purchasers and the<br /> terms of their commitment, if any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>whether<br /> stockholders are entitled to oversubscription rights, if<br /> any;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> applicable material U.S. federal income tax considerations;<br /> and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> other terms of the rights, including terms, procedures and<br /> limitations relating to the distribution, exchange and exercise of<br /> the rights, as applicable.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Each<br /> right will entitle the holder of rights to purchase for cash the<br /> principal amount of shares of common stock, preferred stock or<br /> other securities at the exercise price provided in the applicable<br /> prospectus supplement. Rights may be exercised at any time up to<br /> the close of business on the expiration date for the rights<br /> provided in the applicable prospectus supplement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Holders<br /> may exercise rights as described in the applicable prospectus<br /> supplement. Upon receipt of payment and the rights certificate<br /> properly completed and duly executed at the corporate trust office<br /> of the rights agent or any other office indicated in the prospectus<br /> supplement, we will, as soon as practicable, forward the shares of<br /> common stock, preferred stock or other securities, as applicable,<br /> purchasable upon exercise of the rights. If less than all of the<br /> rights issued in any rights offering are exercised, we may offer<br /> any unsubscribed securities directly to persons other than<br /> stockholders, to or through agents, underwriters or dealers or<br /> through a combination of such methods, including pursuant to<br /> standby arrangements, as described in the applicable prospectus<br /> supplement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Rights<br /> Agent</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> rights agent for any rights we offer will be set forth in the<br /> applicable prospectus supplement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 22 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>DESCRIPTION OF UNITS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> following description, together with the additional information<br /> that we include in any applicable prospectus supplements summarizes<br /> the material terms and provisions of the units that we may offer<br /> under this prospectus. While the terms we have summarized below<br /> will apply generally to any units that we may offer under this<br /> prospectus, we will describe the particular terms of any series of<br /> units in more detail in the applicable prospectus supplement. The<br /> terms of any units offered under a prospectus supplement may differ<br /> from the terms described below.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will incorporate by reference from reports that we file with the<br /> SEC, the form of unit agreement that describes the terms of the<br /> series of units we are offering, and any supplemental agreements,<br /> before the issuance of the related series of units. The following<br /> summaries of material terms and provisions of the units are subject<br /> to, and qualified in their entirety by reference to, all the<br /> provisions of the unit agreement and any supplemental agreements<br /> applicable to a particular series of units. We urge you to read the<br /> applicable prospectus supplements related to the particular series<br /> of units that we may offer under this prospectus, as well as any<br /> related free writing prospectuses and the complete unit agreement<br /> and any supplemental agreements that contain the terms of the<br /> units.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>General</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> may issue units consisting of common stock, preferred stock, one or<br /> more debt securities, warrants, rights for the purchase of common<br /> stock, preferred stock and/or debt securities in one or more<br /> series, in any combination. Each unit will be issued so that the<br /> holder of the unit is also the holder of each security included in<br /> the unit. Thus, the holder of a unit will have the rights and<br /> obligations of a holder of each security included in the unit. The<br /> unit agreement under which a unit is issued may provide that the<br /> securities included in the unit may not be held or transferred<br /> separately, at any time or at any time before a specified<br /> date.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will describe in the applicable prospectus supplement the terms of<br /> the series of units being offered, including:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> designation and terms of the units and of the securities comprising<br /> the units, including whether and under what circumstances those<br /> securities may be held or transferred separately;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> provisions of the governing unit agreement that differ from those<br /> described below; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>any<br /> provisions for the issuance, payment, settlement, transfer or<br /> exchange of the units or of the securities comprising the<br /> units.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> provisions described in this section, as well as those set forth in<br /> any prospectus supplement or as described under “Description of<br /> Common Stock,” “Description of Preferred Stock,” “Description of<br /> Debt Securities,” “Description of Warrants” and “Description of<br /> Rights” will apply to each unit, as applicable, and to any common<br /> stock, preferred stock, debt security, warrant or right included in<br /> each unit, as applicable.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Unit<br /> Agent</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> name and address of the unit agent for any units we offer will be<br /> set forth in the applicable prospectus supplement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Issuance<br /> in Series</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> may issue units in such amounts and in such numerous distinct<br /> series as we determine.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>Enforceability<br /> of Rights by Holders of Units</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Each<br /> unit agent will act solely as our agent under the applicable unit<br /> agreement and will not assume any obligation or relationship of<br /> agency or trust with any holder of any unit. A single bank or trust<br /> company may act as unit agent for more than one series of units. A<br /> unit agent will have no duty or responsibility in case of any<br /> default by us under the applicable unit agreement or unit,<br /> including any duty or responsibility to initiate any proceedings at<br /> law or otherwise, or to make any demand upon us. Any holder of a<br /> unit may, without the consent of the related unit agent or the<br /> holder of any other unit, enforce by appropriate legal action its<br /> rights as holder under any security included in the<br /> unit.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 23 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>CERTAIN<br /> PROVISIONS OF DELAWARE LAW AND OF THE COMPANY’S CERTIFICATE OF<br />INCORPORATION AND BYLAWS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; COLOR: #231F20"> <span><b>Anti-Takeover<br /> Provisions</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; COLOR: #231F20"> <span><b><i><br /> Delaware Law</i></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; COLOR: #231F20"> <span>We<br /> are subject to the anti-takeover provisions of Section 203 of the<br /> Delaware General Corporation Law, or DGCL. Section 203 prohibits a<br /> publicly-held Delaware corporation from engaging in a “business<br /> combination” with an “interested stockholder” for a period of three<br /> years after the date of the transaction in which the person became<br /> an interested stockholder, unless the business combination is, or<br /> the transaction in which the person became an interested<br /> stockholder was, approved in a prescribed manner or another<br /> prescribed exception applies. For purposes of Section 203, a<br /> “business combination” is defined broadly to include a merger,<br /> asset sale or other transaction resulting in a financial benefit to<br /> the interested stockholder, and, subject to certain exceptions, an<br /> “interested stockholder” is a person who, together with his or her<br /> affiliates and associates, owns, or within three years prior, did<br /> own, 15% or more of the corporation’s voting stock.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; COLOR: #231F20"> <span><b><i><br /> Staggered Board</i></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> restated certificate of incorporation and restated by-laws provide<br /> for the Board of Directors to be divided into three classes serving<br /> staggered terms. At each annual meeting of stockholders, directors<br /> elected to succeed those directors whose terms expire are elected<br /> for a three-year term of office. All directors elected to our<br /> classified Board of Directors will serve until the election and<br /> qualification of their respective successors or their earlier<br /> resignation or removal. The Board of Directors is authorized to<br /> create new directorships and to fill such positions so created and<br /> is permitted to specify the class to which any such new position is<br /> assigned. The person filling such position would serve for the term<br /> applicable to that class. The Board of Directors (or its remaining<br /> members, even if less than a quorum) is also empowered to fill<br /> vacancies on the Board of Directors occurring for any reason for<br /> the remainder of the term of the class of directors in which the<br /> vacancy occurred. Members of the Board of Directors may only be<br /> removed for cause and only by the affirmative vote of 80% of the<br /> outstanding voting stock. These provisions are likely to increase<br /> the time required for stockholders to change the composition of the<br /> Board of Directors. For example, in general, at least two annual<br /> meetings will be necessary for stockholders to effect a change in a<br /> majority of the members of the Board of Directors. The provision<br /> for a classified board could prevent a party who acquires control<br /> of a majority of our outstanding common stock from obtaining<br /> control of our Board of Directors until our second annual<br /> stockholders meeting following the date the acquirer obtains the<br /> controlling stock interest. The classified board provision could<br /> have the effect of discouraging a potential acquirer from making a<br /> tender offer or otherwise attempting to obtain control of us and<br /> could increase the likelihood that incumbent directors will retain<br /> their positions.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b><i><br /> Advance notice provisions for stockholder<br /> proposals</i></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> restated by-laws establish an advance notice procedure for<br /> stockholder nominations of candidates for election to our Board of<br /> Directors, as well as procedures for including proposed nominations<br /> at special meetings at which directors are to be elected.<br /> Stockholders at our annual meeting may only consider proposals or<br /> nominations specified in the notice of meeting or brought before<br /> the meeting by or at the direction of our board or by a stockholder<br /> who was a stockholder of record on the record date for the meeting,<br /> who is entitled to vote at the meeting and who has given to our<br /> secretary timely written notice, in proper form, of the<br /> stockholder’s intention to bring that business before the meeting,<br /> and who has complied with the procedures and requirements set forth<br /> in the by-laws. Although the by-laws do not give the Board of<br /> Directors the power to approve or disapprove stockholder<br /> nominations of candidates or proposals regarding other business to<br /> be conducted at a special or annual meeting, these by-laws may have<br /> the effect of precluding the conduct of some business at a meeting<br /> if the proper procedures are not followed or may discourage or<br /> defer a potential acquirer from conducting a solicitation of<br /> proxies to elect its own slate of directors or otherwise attempting<br /> to obtain control of Microbot.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 24 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b><i><br />  </i></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b><i><br /> Special meetings of stockholders</i></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Special<br /> meetings of the stockholders may be called only by the Board of<br /> Directors, president or secretary upon the application of a<br /> majority of the directors. Stockholders are not permitted to call a<br /> special meeting or to require our Board of Directors to call a<br /> special meeting.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b><i><br /> No stockholder action by written consent</i></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> restated certificate of incorporation and restated by-laws do not<br /> permit our stockholders to act by written consent. As a result, any<br /> action to be effected by our stockholders must be effected at a<br /> duly called annual or special meeting of the<br /> stockholders.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 24.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b><i><br /> Super-majority stockholder vote required for certain<br /> actions.</i></b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> DGCL provides generally that the affirmative vote of a majority of<br /> the shares entitled to vote on any matter is required to amend a<br /> corporation’s certificate of incorporation or by-laws, unless the<br /> corporation’s certificate of incorporation or by-laws, as the case<br /> may be, requires a greater percentage. Our restated certificate of<br /> incorporation requires the affirmative vote of the holders of at<br /> least 80% of our outstanding voting stock to amend or repeal<br /> certain provisions of our restated certificate of incorporation.<br /> This 80% stockholder vote would be in addition to any separate<br /> class vote that might in the future be required pursuant to the<br /> terms of any preferred stock that might then be outstanding. In<br /> addition, an 80% vote is also required for any amendment to, or<br /> repeal of, our restated by-laws by the stockholders. Our restated<br /> by-laws may be amended or repealed by a vote of a majority of the<br /> total number of authorized directors.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 24.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; COLOR: #231F20"> <span><b>Limitation<br /> of Liability and Indemnification</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Our<br /> restated certificate of incorporation and our amended and restated<br /> bylaws provide that each person who was or is made a party or is<br /> threatened to be made a party to or is otherwise involved<br /> (including, without limitation, as a witness) in any action, suit<br /> or proceeding, whether civil, criminal, administrative or<br /> investigative, by reason of the fact that he or she is or was one<br /> of our directors or officers or is or was serving at our request as<br /> a director, officer, or trustee of another corporation, or of a<br /> partnership, joint venture, trust or other enterprise, including<br /> service with respect to an employee benefit plan, whether the basis<br /> of such proceeding is alleged action in an official capacity as a<br /> director, officer or trustee or in any other capacity while serving<br /> as a director, officer or trustee, shall be indemnified and held<br /> harmless by us to the fullest extent authorized by the DGCL against<br /> all expense, liability and loss (including attorneys’ fees,<br /> judgments, fines, ERISA excise taxes or penalties and amounts paid<br /> in settlement) reasonably incurred or suffered by such.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Section<br /> 145 of the DGCL permits a corporation to indemnify any director or<br /> officer of the corporation against expenses (including attorneys’<br /> fees), judgments, fines and amounts paid in settlement actually and<br /> reasonably incurred in connection with any action, suit or<br /> proceeding brought by reason of the fact that such person is or was<br /> a director or officer of the corporation, if such person acted in<br /> good faith and in a manner that he or she reasonably believed to be<br /> in, or not opposed to, the best interests of the corporation, and,<br /> with respect to any criminal action or proceeding, if he or she had<br /> no reasonable cause to believe his or her conduct was unlawful. In<br /> a derivative action (i.e., one brought by or on behalf of the<br /> corporation), indemnification may be provided only for expenses<br /> actually and reasonably incurred by any director or officer in<br /> connection with the defense or settlement of such an action or suit<br /> if such person acted in good faith and in a manner that he or she<br /> reasonably believed to be in, or not opposed to, the best interests<br /> of the corporation, except that no indemnification shall be<br /> provided if such person shall have been adjudged to be liable to<br /> the corporation, unless and only to the extent that the Delaware<br /> Chancery Court or the court in which the action or suit was brought<br /> shall determine that such person is fairly and reasonably entitled<br /> to indemnity for such expenses despite such adjudication of<br /> liability.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Pursuant<br /> to Section 102(b)(7) of the DGCL, Article Ninth of our restated<br /> certificate of incorporation eliminates the liability of a director<br /> to us or our stockholders for monetary damages for such a breach of<br /> fiduciary duty as a director, except for liabilities<br /> arising:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.5IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>from<br /> any breach of the director’s duty of loyalty to us or our<br /> stockholders;</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 25 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.5IN"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>from<br /> acts or omissions not in good faith or which involve intentional<br /> misconduct or a knowing violation of law;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>under<br /> Section 174 of the DGCL; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>from<br /> any transaction from which the director derived an improper<br /> personal benefit.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.25IN; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; COLOR: #231F20"> <span>We<br /> have entered into indemnification agreements with our directors and<br /> certain officers, in addition to the indemnification provided in<br /> our restated certificate of incorporation and our amended and<br /> restated bylaws, and intend to enter into indemnification<br /> agreements with any new directors and executive officers in the<br /> future. We have purchased and intend to maintain insurance on<br /> behalf of any person who is or was a director or officer against<br /> any loss arising from any claim asserted against him or her and<br /> incurred by him or her in any such capacity, subject to certain<br /> exclusions.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN; COLOR: #231F20"> <span>The<br /> foregoing discussion of our restated certificate of incorporation,<br /> amended and restated bylaws, indemnification agreements, indemnity<br /> agreement, and Delaware law is not intended to be exhaustive and is<br /> qualified in its entirety by such restated certificate of<br /> incorporation, amended and restated bylaws, indemnification<br /> agreements, indemnity agreement, or law.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>LEGAL MATTERS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> validity of the shares being offered under this prospectus by us<br /> will be passed upon for us by Mintz, Levin, Cohn, Ferris, Glovsky<br /> and Popeo, P.C., Boston, Massachusetts.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>EXPERTS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> consolidated financial statements of Microbot Medical Inc.<br /> appearing it its Annual Report on Form 10-K for the year ended<br /> December 31, 2019, have been audited by <span>Brightman Almagor Zohar & Co., a firm<br /> in the Deloitte Global Network,</span> independent registered<br /> public accounting firm, as set forth in their report thereon,<br /> including therein, and incorporated herein by reference. Such<br /> consolidated financial statements are incorporated herein by<br /> reference in reliance upon such report given on the authority of<br /> such firm as experts in accounting and auditing.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>WHERE YOU CAN FIND MORE<br /> INFORMATION</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> are subject to the reporting requirements of the Exchange Act and<br /> file annual, quarterly and current reports, proxy statements and<br /> other information with the SEC. SEC filings are available at the<br /> SEC’s website at http://www.sec.gov.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>This<br /> prospectus is only part of a registration statement on Form S-3<br /> that we have filed with the SEC under the Securities Act and<br /> therefore omits certain information contained in the registration<br /> statement. We have also filed exhibits and schedules with the<br /> registration statement that are excluded from this prospectus, and<br /> you should refer to the applicable exhibit or schedule for a<br /> complete description of any statement referring to any contract or<br /> other document.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> registration statement and the documents referred to below under<br /> “Incorporation of Certain Information by Reference” are also<br /> available on our website at http://www.microbotmedical.com. We have<br /> not incorporated by reference into this prospectus the information<br /> on our website, and you should not consider it to be a part of this<br /> prospectus.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>INCORPORATION OF DOCUMENTS BY<br /> REFERENCE</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> SEC allows us to “incorporate by reference” information that we<br /> file with them. Incorporation by reference allows us to disclose<br /> important information to you by referring you to those other<br /> documents. The information incorporated by reference is an<br /> important part of this prospectus, and information that we file<br /> later with the SEC will automatically update and supersede this<br /> information. We filed a registration statement on Form S-3 under<br /> the Securities Act with the SEC with respect to the securities we<br /> may offer pursuant to this prospectus. This prospectus omits<br /> certain information contained in the registration statement, as<br /> permitted by the SEC. You should refer to the registration<br /> statement, including the exhibits, for further information about us<br /> and the securities we may offer pursuant to this prospectus.<br /> Statements in this prospectus regarding the provisions of certain<br /> documents filed with, or incorporated by reference in, the<br /> registration statement are not necessarily complete and each<br /> statement is qualified in all respects by that reference. Copies of<br /> all or any part of the registration statement, including the<br /> documents incorporated by reference or the exhibits, are available<br /> at the SEC’s website at http://www.sec.gov. The documents we are<br /> incorporating by reference are:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 26 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.5IN; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>our<br /> Annual Report on Form 10-K for the year ended December 31, 2019<br /> filed with the SEC on April 14, 2020 and Amendment No. 1 to our<br /> Annual Report on Form 10-K for the year ended December 31, 2019<br /> filed on April 29, 2020;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>our<br /> Quarterly Reports on Form 10-Q for the quarters ended March 31,<br /> 2020, June 30, 2020 and September 30, 2020 that we filed with the<br /> SEC on May 15, 2020, August 14, 2020 and November 16,<br /> 2020.</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY">  </td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY">  </td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY">  </td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>our<br /> Current Reports on Form 8-K, filed with the SEC (except for the<br /> information furnished under Items 2.02 or 7.01 and the exhibits<br /> furnished thereto) on: February 25, 2020, February 28, 2020, March<br /> 3, 2020, April 1, 2020, May 7, 2020, June 19, 2020, August 3, 2020<br /> and September 4, 2020;</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>the<br /> description of our common stock contained in our registration<br /> statement on Form 8-A filed August 3, 1998, under the Exchange Act,<br /> including any amendment or report filed for the purpose of updating<br /> such description; and</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>●</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>all<br /> reports and other documents subsequently filed by us pursuant to<br /> Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the<br /> date of this prospectus and prior to the termination of this<br /> offering.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> SEC file number for each of the documents listed above is<br /> 000-19871</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>In<br /> addition, all reports and other documents filed by us pursuant to<br /> the Exchange Act after the date of the initial registration<br /> statement and prior to effectiveness of the registration statement<br /> shall be deemed to be incorporated by reference into this<br /> prospectus.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Any<br /> statement contained in this prospectus or in a document<br /> incorporated or deemed to be incorporated by reference into this<br /> prospectus will be deemed to be modified or superseded for purposes<br /> of this prospectus to the extent that a statement contained in this<br /> prospectus or any other subsequently filed document that is deemed<br /> to be incorporated by reference into this prospectus modifies or<br /> supersedes the statement. Any statement so modified or superseded<br /> will not be deemed, except as so modified or superseded, to<br /> constitute a part of this prospectus.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> will provide, upon written or oral request, without charge to each<br /> person, including any beneficial owner, to whom a copy of this<br /> prospectus is delivered, a copy of any or all of the information<br /> incorporated herein by reference (exclusive of exhibits to such<br /> documents unless such exhibits are specifically incorporated by<br /> reference herein). You may request a copy of any or all of these<br /> filings, at no cost, by writing or telephoning us at: Microbot<br /> Medical Inc., 25 Recreation Park Drive, Unit 108, Hingham, MA<br /> 02043; Attention: Harel Gadot; telephone number (908)<br /> 938-5561.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>You<br /> should rely only on information contained in, or incorporated by<br /> reference into, this prospectus and any prospectus supplement. We<br /> have not authorized anyone to provide you with information<br /> different from that contained in this prospectus or incorporated by<br /> reference in this prospectus. We are not making offers to sell the<br /> securities in any jurisdiction in which such an offer or<br /> solicitation is not authorized or in which the person making such<br /> offer or solicitation is not qualified to do so or to anyone to<br /> whom it is unlawful to make such offer or solicitation.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 27 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span><b>PART<br /> II</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span><b>INFORMATION<br /> NOT REQUIRED IN PROSPECTUS</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT"> <span><b>Item<br /> 14. Other Expenses of Issuance and Distribution.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> following table sets forth the various expenses in connection with<br /> the sale and distribution of the securities being registered, all<br /> of which are being borne by us.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; BACKGROUND-COLOR: WHITE"> <span> </span></p> <table cellpadding="0" cellspacing="0" align="center" style="BORDER-COLLAPSE: COLLAPSE; WIDTH: 70%; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td style="WIDTH: 80%; TEXT-ALIGN: LEFT"><span>Securities and<br /> Exchange Commission registration fee</span></td> <td style="WIDTH: 2%"><span> </span></td> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"><span>$</span></td> <td style="WIDTH: 16%; TEXT-ALIGN: RIGHT">8,182.50</td> <td style="WIDTH: 1%; TEXT-ALIGN: LEFT"/> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE"> <td style="TEXT-ALIGN: LEFT"><span>Printing and engraving<br /> expenses</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>*</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td style="TEXT-ALIGN: LEFT"><span>Legal fees and<br /> expenses</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>*</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE"> <td style="TEXT-ALIGN: LEFT"><span>Accounting fees and<br /> expenses</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>*</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td style="TEXT-ALIGN: LEFT"><span>Blue sky fees and<br /> expenses</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>*</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE"> <td style="TEXT-ALIGN: LEFT"><span>Transfer Agent and<br /> Registrar fees</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>*</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td style="TEXT-ALIGN: LEFT"><span>Trust fees and<br /> expenses</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>*</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE"> <td><span>Miscellaneous</span></td> <td><span> </span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> <td style="TEXT-ALIGN: RIGHT"><span>*</span></td> <td style="TEXT-ALIGN: LEFT"><span> </span></td> </tr> <tr style="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: RGB(204,238,255)"> <td style="PADDING-LEFT: 10PT; FONT-WEIGHT: BOLD"><span>Total</span></td> <td style="FONT-WEIGHT: BOLD"><span> </span></td> <td style="FONT-WEIGHT: BOLD; TEXT-ALIGN: LEFT"><span> </span></td> <td style="FONT-WEIGHT: BOLD; TEXT-ALIGN: RIGHT"><span><b>*</b></span></td> <td style="FONT-WEIGHT: BOLD; TEXT-ALIGN: LEFT"><span> </span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="WIDTH: 1IN"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>*</span></td> <td style="TEXT-ALIGN: JUSTIFY; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"> <span>The<br /> amount of securities and number of offerings are indeterminable and<br /> cannot be estimated at this time.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT"> <span><b>Item<br /> 15. Indemnification of Directors and Officers.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 27PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Section<br /> 145 of the DGCL provides that a corporation has the power to<br /> indemnify a director, officer, employee, or agent of the<br /> corporation, or a person serving at the request of the corporation<br /> for another corporation, partnership, joint venture, trust or other<br /> enterprise in related capacities against expenses, including<br /> attorneys’ fees, judgments, fines and amounts paid in settlement<br /> actually and reasonably incurred by the person in connection with<br /> an action, suit or proceeding to which he was or is a party or is<br /> threatened to be made a party to any threatened, ending or<br /> completed action, suit or proceeding by reason of such position, if<br /> such person acted in good faith and in a manner he reasonably<br /> believed to be in or not opposed to the best interests of the<br /> corporation, and, in any criminal action or proceeding, had no<br /> reasonable cause to believe his conduct was unlawful, except that,<br /> in the case of actions brought by or in the right of the<br /> corporation, no indemnification shall be made with respect to any<br /> claim, issue or matter as to which such person shall have been<br /> adjudged to be liable to the corporation unless and only to the<br /> extent that the Court of Chancery or other adjudicating court<br /> determines that, despite the adjudication of liability but in view<br /> of all of the circumstances of the case, such person is fairly and<br /> reasonably entitled to indemnity for such expenses which the Court<br /> of Chancery or such other court shall deem proper.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 27PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Section<br /> 102 of the DGCL, permits a corporation to eliminate the personal<br /> liability of directors of a corporation to the corporation or its<br /> stockholders for monetary damages for a breach of fiduciary duty as<br /> a director, except where the director breached his duty of loyalty,<br /> failed to act in good faith, engaged in intentional misconduct or<br /> knowingly violated a law, authorized the payment of a dividend or<br /> approved a stock repurchase in violation of Delaware corporate law<br /> or obtained an improper personal benefit.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 27PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> foregoing discussion of indemnification merely summarizes certain<br /> aspects of indemnification provisions of, and is limited by<br /> reference to, the above discussed sections of the DGCL.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 24.5PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> Company’s restated certificate of incorporation provides that the<br /> Company’s Directors shall not be liable to the Company or its<br /> stockholders for monetary damages for breach of fiduciary duty as a<br /> director except to the extent that exculpation from liabilities is<br /> not permitted under the DGCL as in effect at the time such<br /> liability is determined. The Company’s restated certificate of<br /> incorporation further provides that the Company shall indemnify its<br /> directors and officers to the fullest extent permitted by the<br /> DGCL.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 24.5PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 28; OPTIONS: NEWSECTION; VALUE: 1 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> maintain a directors’ and officers’ insurance policy pursuant to<br /> which our directors and officers are insured against liability for<br /> actions taken in their capacities as directors and officers. We<br /> believe that these indemnification provisions and insurance are<br /> necessary to attract and retain qualified directors and<br /> officers.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 24.5PT; BACKGROUND-COLOR: WHITE"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><i>Indemnification<br /> Agreements</i></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>We<br /> have entered into indemnification agreements with each of our<br /> directors and officers. These indemnification agreements may<br /> require us, among other things, to indemnify our directors and<br /> officers for some expenses, including attorneys’ fees, judgments,<br /> fines and settlement amounts incurred by a director or officer in<br /> any action or proceeding arising out of his or her service as one<br /> of our directors or officers, or any of our subsidiaries or any<br /> other company or enterprise to which the person provides services<br /> at our request.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0"> <span><b>Item<br /> 16. Exhibits.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>The<br /> exhibits to this registration statement are listed in the Exhibit<br /> Index to this registration statement, which Exhibit Index is hereby<br /> incorporated by reference.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0"> <span><b>Item<br /> 17. Undertakings.</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>(a)<br /> The undersigned registrant hereby undertakes:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span>(1)<br /> To file, during any period in which offers or sales are being made,<br /> a post-effective amendment to this registration<br /> statement:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(i)<br /> To include any prospectus required by section 10(a)(3) of the<br /> Securities Act of 1933;</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(ii)<br /> To reflect in the prospectus any facts or events arising after the<br /> effective date of the registration statement (or the most recent<br /> post-effective amendment thereof) which, individually or in the<br /> aggregate, represent a fundamental change in the information set<br /> forth in the registration statement. Notwithstanding the foregoing,<br /> any increase or decrease in volume of securities offered (if the<br /> total dollar value of securities offered would not exceed that<br /> which was registered) and any deviation from the low or high end of<br /> the estimated maximum offering range may be reflected in the form<br /> of prospectus filed with the Commission pursuant to Rule 424(b) if,<br /> in the aggregate, the changes in volume and price represent no more<br /> than a 20% change in the maximum aggregate offering price set forth<br /> in the “Calculation of Registration Fee” table in the effective<br /> registration statement; and</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(iii)<br /> To include any material information with respect to the plan of<br /> distribution not previously disclosed in the registration statement<br /> or any material change to such information in the registration<br /> statement; <i>provided</i>, <i>however</i>, that paragraphs<br /> (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) do not apply if the<br /> information required to be included in a post-effective amendment<br /> by those paragraphs is contained in reports filed with or furnished<br /> to the Commission by the registrant pursuant to section 13 or<br /> section 15(d) of the Securities Exchange Act of 1934 that are<br /> incorporated by reference in the registration statement, or is<br /> contained in a form of prospectus filed pursuant to Rule 424(b)<br /> that is part of the registration statement.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span>(2)<br /> That, for the purpose of determining any liability under the<br /> Securities Act of 1933, each such post-effective amendment shall be<br /> deemed to be a new registration statement relating to the<br /> securities offered therein, and the offering of such securities at<br /> that time shall be deemed to be the initial bona fide offering<br /> thereof.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span>(3)<br /> To remove from registration by means of a post-effective amendment<br /> any of the securities being registered which remain unsold at the<br /> termination of the offering.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span>(4)<br /> That, for the purpose of determining liability under the Securities<br /> Act of 1933 to any purchaser:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(i)<br /> Each prospectus filed by the registrant pursuant to Rule 424(b)(3)<br /> shall be deemed to be part of the registration statement as of the<br /> date the filed prospectus was deemed part of and included in the<br /> registration statement; and</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 29; VALUE: 1 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(ii)<br /> Each prospectus required to be filed pursuant to Rule 424(b)(2),<br /> (b)(5), or (b)(7) as part of a registration statement in reliance<br /> on Rule 430B relating to an offering made pursuant to Rule<br /> 415(a)(1)(i), (vii), or (x) for the purpose of providing the<br /> information required by section 10(a) of the Securities Act of 1933<br /> shall be deemed to be part of and included in the registration<br /> statement as of the earlier of the date such form of prospectus is<br /> first used after effectiveness or the date of the first contract of<br /> sale of securities in the offering described in the prospectus. As<br /> provided in Rule 430B, for liability purposes of the issuer and any<br /> person that is at that date an underwriter, such date shall be<br /> deemed to be a new effective date of the registration statement<br /> relating to the securities in the registration statement to which<br /> that prospectus relates, and the offering of such securities at<br /> that time shall be deemed to be the initial <i>bona fide</i><br /> offering thereof. <i>Provided</i>, <i>however</i>, that no<br /> statement made in a registration statement or prospectus that is<br /> part of the registration statement or made in a document<br /> incorporated or deemed incorporated by reference into the<br /> registration statement or prospectus that is part of the<br /> registration statement will, as to a purchaser with a time of<br /> contract of sale prior to such effective date, supersede or modify<br /> any statement that was made in the registration statement or<br /> prospectus that was part of the registration statement or made in<br /> any such document immediately prior to such effective<br /> date.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.25IN"> <span>(5)<br /> That, for the purpose of determining liability of the registrant<br /> under the Securities Act of 1933 to any purchaser in the initial<br /> distribution of the securities, in a primary offering of securities<br /> of the undersigned registrant pursuant to this registration<br /> statement, regardless of the underwriting method used to sell the<br /> securities to the purchaser, if the securities are offered or sold<br /> to such purchaser by means of any of the following communications,<br /> the undersigned registrant will be a seller to the purchaser and<br /> will be considered to offer or sell such securities to such<br /> purchaser:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(i)<br /> Any preliminary prospectus or prospectus of the undersigned<br /> registrant relating to the offering required to be filed pursuant<br /> to Rule 424;</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(ii)<br /> Any free writing prospectus relating to the offering prepared by or<br /> on behalf of the undersigned registrant or used or referred to by<br /> the undersigned registrant;</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(iii)<br /> The portion of any other free writing prospectus relating to the<br /> offering containing material information about the undersigned<br /> registrant or its securities provided by or on behalf of the<br /> undersigned registrant; and</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(iv)<br /> Any other communication that is an offer in the offering made by<br /> the undersigned registrant to the purchaser.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>(b)<br /> That, for purposes of determining any liability under the<br /> Securities Act:</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(i)<br /> the information omitted from the form of prospectus filed as part<br /> of the registration statement in reliance upon Rule 430A and<br /> contained in the form of prospectus filed by the registrant<br /> pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities<br /> Act shall be deemed to be part of the registration statement as of<br /> the time it was declared effective; and</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 40.5PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 22.5PT"> <span>(ii)<br /> each post-effective amendment that contains a form of prospectus<br /> shall be deemed to be a new registration statement relating to the<br /> securities offered therein, and the offering of such securities at<br /> that time shall be deemed to be the initial <i>bona fide</i><br /> offering thereof.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>(c)<br /> The undersigned registrant hereby undertakes that, for purposes of<br /> determining any liability under the Securities Act of 1933, each<br /> filing of the registrant’s annual report pursuant to section 13(a)<br /> or section 15(d) of the Securities Exchange Act of 1934 (and, where<br /> applicable, each filing of an employee benefit plan’s annual report<br /> pursuant to section 15(d) of the Securities Exchange Act of 1934)<br /> that is incorporated by reference in the registration statement<br /> shall be deemed to be a new registration statement relating to the<br /> securities offered therein, and the offering of such securities at<br /> that time shall be deemed to be the initial bona fide offering<br /> thereof.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>(d)<br /> Insofar as indemnification for liabilities arising under the<br /> Securities Act of 1933 may be permitted to directors, officers and<br /> controlling persons of the registrant, the registrant has been<br /> advised that in the opinion of the Securities and Exchange<br /> Commission such indemnification is against public policy as<br /> expressed in the Act and is, therefore, unenforceable. In the event<br /> that a claim for indemnification against such liabilities (other<br /> than the payment by the registrant of expenses incurred or paid by<br /> a director, officer or controlling person of the registrant in the<br /> successful defense of any action, suit or proceeding) is asserted<br /> by such director, officer or controlling person in connection with<br /> the securities being registered, the registrant will, unless in the<br /> opinion of its counsel the matter has been settled by controlling<br /> precedent, submit to a court of appropriate jurisdiction the<br /> question whether such indemnification by it is against public<br /> policy as expressed in the Act and will be governed by the final<br /> adjudication of such issue.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.25IN; TEXT-ALIGN: JUSTIFY"> <span>(e)<br /> The undersigned registrant hereby undertakes to file an application<br /> for the purpose of determining the eligibility of the trustee to<br /> act under subsection (a) of Section 310 of the Trust Indenture Act<br /> (“Act”) in accordance with the rules and regulations prescribed by<br /> the Commission under section 305(b)(2) of the Act.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 30; VALUE: 1 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>SIGNATURES</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span>Pursuant<br /> to the requirements of the Securities Act of 1933, the registrant<br /> certifies that it has reasonable grounds to believe that it meets<br /> all of the requirements for filing on Form S-3 and has duly caused<br /> this registration statement to be signed on its behalf by the<br /> undersigned, thereunto duly authorized, in the City of Hingham,<br /> State of Massachusetts, on the 25<sup>th</sup> day of November,<br /> 2020.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td colspan="2" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"> <span><b>MICROBOT<br /> MEDICAL INC.</b></span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 50%"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 3%"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 47%"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>By:</span></td> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"> <span><i>/s/<br /> Harel Gadot</i></span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Harel<br /> Gadot</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span><i>Chairman,<br /> President and Chief Executive Officer</i></span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span><b>SIGNATURES AND POWER OF<br /> ATTORNEY</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 24.5PT"> <span>Each<br /> person whose signature appears below hereby constitutes and<br /> appoints Harel Gadot and David Ben Naim, and each of them singly,<br /> his or her true and lawful attorneys-in-fact and agent with full<br /> power of substitution and resubstitution, for him or her and in his<br /> or her name, place and stead, in any and all capacities, to sign<br /> any and all amendments (including post-effective amendments) to<br /> this Registration Statement on Form S-3 and any related Rule 462(b)<br /> registration statement or amendment thereto and to file the same,<br /> with all exhibits thereto, and other documents in connection<br /> therewith, with the Securities and Exchange Commission, granting<br /> unto said attorneys-in-fact and agents full power and authority to<br /> be done in and about the premises, as fully to all intents and<br /> purposes as he or she might or could do in person, hereby ratifying<br /> and confirming all that said attorneys-in-fact and agents, or their<br /> substitutes, may lawfully do or cause to be done by virtue<br /> hereof.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 24.5PT"> <span> </span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 24.5PT"> <span>Pursuant<br /> to the requirements of the Securities Act, this registration<br /> statement has been signed by the following persons in the<br /> capacities and on the dates indicated.</span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 30%"> <span><b>Signature</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 2%"> <span> </span></td> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 46%"> <span><b>Title</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 2%"> <span> </span></td> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 20%"> <span><b>Date</b></span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><i>/s/<br /> Harel Gadot</i></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Chairman,<br /> President and Chief Executive Officer</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>November<br /> 25, 2020</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>Harel<br /> Gadot</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>(Principal<br /> Executive Officer)</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><i>/s/<br /> David Ben Naim</i></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Chief<br /> Financial Officer</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>November<br /> 25, 2020</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>David<br /> Ben Naim</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>(Principal<br /> Financial and Accounting Officer)</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><i>/s/<br /> Tal Wenderow</i></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Director</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>November<br /> 25, 2020</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>Tal<br /> Wenderow</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><i>/s/<br /> Yoseph Bornstein</i></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Director</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>November<br /> 25, 2020</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>Yoseph<br /> Bornstein</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><i>/s/<br /> Prattipati Laxminarain</i></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Director</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>November<br /> 25, 2020</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>Prattipati<br /> Laxminarain</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><i>/s/<br /> Scott Burell</i></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Director</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>November<br /> 25, 2020</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>Scott<br /> Burell</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><i>/s/<br /> Martin Madden</i></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Director</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>November<br /> 25, 2020</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>Martin<br /> Madden</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><i>/s/<br /> Aileen Stockburger</i></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Director</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>November<br /> 25, 2020</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>Aileen<br /> Stockburger</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 31; VALUE: 1 --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span><b> </b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span><b>EXHIBIT<br /> INDEX</b></span></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.5IN"> <span><b>Exhibit</b></span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.1IN"> <span> </span></td> <td style="BORDER-BOTTOM: BLACK 1.5PT SOLID; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><b>Description</b></span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>1.1*</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Form<br /> of underwriting agreement</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>3.1</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Restated<br /> Certificate of Incorporation of the Registrant (incorporated by<br /> reference to Exhibit 3.1 of the Registrant’s Annual Report on Form<br /> 10-K, filed on March 15, 2007)</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>3.2</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Certificate<br /> of Amendment to the Restated Certificate of Incorporation of the<br /> Registrant (incorporated by reference to Exhibit 3.1 of Current<br /> Report on Form 8-K, filed on November 29, 2016)</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>3.3</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Certificate<br /> of Amendment to the Restated Certificate of Incorporation<br /> (incorporated by reference to the Company’s Current Report on Form<br /> 8-K filed on September 4, 2018).</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>3.4</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Certificate<br /> of Amendment to the Restated Certificate of Incorporation<br /> (incorporated by reference to the Company’s Current Report on Form<br /> 8-K filed on September 11, 2019).</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>3.5</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Amended<br /> and Restated By-Laws of the Company (incorporated by reference to<br /> the Company’s Current Report on Form 8-K filed on May 3,<br /> 2016).</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>4.1*</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Form<br /> of Common Stock Warrant Agreement and Warrant<br /> Certificate</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>4.2*</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Form<br /> of Preferred Stock Warrant Agreement and Warrant<br /> Certificate</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>4.3*</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Form<br /> of Debt Securities Warrant Agreement and Warrant<br /> Certificate</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>4.4**</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Form<br /> of Senior Indenture</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>4.5**</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Form<br /> of Subordinated Indenture</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>4.6*</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Form<br /> of Rights Agreement and Right Certificate</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>4.7*</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Form<br /> of Unit Agreement and Unit</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>5.1**</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Opinion<br /> of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo,<br /> P.C.</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>23.1**</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Consent<br /> of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in<br /> Exhibit 5.1)</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>23.2**</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span><br /> Consent of Brightman Almagor Zohar & Co., a firm in the<br /> Deloitte Global Network</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>24.1</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Power<br /> of attorney—included on the signature page</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span> </span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>25.1***</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span> </span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>Statement<br /> of Eligibility of Trustee Under Debt Indenture</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY"> <span> </span></p> <table cellspacing="0" cellpadding="0" style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE"> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 0.25IN"> <span>*</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; TEXT-ALIGN: JUSTIFY"> <span>To be<br /> filed, if necessary, subsequent to the effectiveness of this<br /> registration statement by an amendment to this registration<br /> statement or incorporated by reference pursuant to a Current Report<br /> on Form 8-K in connection with an offering of<br /> securities.</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>**</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>Filed<br /> herewith.</span></td> </tr> <tr style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP"> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>***</span></td> <td style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF"><span>To be<br /> filed separately pursuant to Section 305(b)(2) of the Trust<br /> Indenture Act of 1939.</span></td> </tr> </table> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PT"> <span> </span></p> <p><!-- FIELD: PAGE; SEQUENCE: 32; OPTIONS: LAST --></p> <p><!-- FIELD: /PAGE --></p> <p style="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0"> <span> </span></p> <div style="margin-top: 10px; padding-top: 10px; border-top: 2px solid lightgrey;"> <div style="width: 320px; text-align: center; display: inline-table;"> Microbot Medical (NASDAQ:MBOT)<br />Historical Stock Chart<br />From Dec 2020 to Jan 2021</p> <p><img loading="lazy" data-symbol="N%5EMBOT" data-period="1" data-type="15" border="0" src="https://ih.advfn.com/p.php?pid=staticchart&s=N%5EMBOT&p=1&t=15&width=280&height=175" width="280" height="175" title="Click Here for more Microbot Medical Charts." alt="Click Here for more Microbot Medical Charts." itemprop="image"/></p></div> <div style="width: 320px; text-align: center; display: inline-table;"> Microbot Medical (NASDAQ:MBOT)<br />Historical Stock Chart<br />From Jan 2020 to Jan 2021</p> <p><img loading="lazy" data-symbol="N%5EMBOT" data-period="5" data-type="15" border="0" src="https://ih.advfn.com/p.php?pid=staticchart&s=N%5EMBOT&p=5&t=15&width=280&height=175" width="280" height="175" title="Click Here for more Microbot Medical Charts." alt="Click Here for more Microbot Medical Charts." itemprop="image"/></p></div> </p></div> </p></div> </div><!-- .entry-content --> <footer class="entry-footer"> <span class="byline"><svg class="svg-icon" width="16" height="16" aria-hidden="true" role="img" focusable="false" viewBox="0 0 24 24" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><path d="M12 12c2.21 0 4-1.79 4-4s-1.79-4-4-4-4 1.79-4 4 1.79 4 4 4zm0 2c-2.67 0-8 1.34-8 4v2h16v-2c0-2.66-5.33-4-8-4z"></path><path d="M0 0h24v24H0z" fill="none"></path></svg><span class="screen-reader-text">Publié par</span><span class="author vcard"><a class="url fn n" href="https://humbot.io/author/y97u97r97i">Y97U97R97I</a></span></span><span class="posted-on"><svg class="svg-icon" width="16" height="16" aria-hidden="true" role="img" focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><defs><path id="a" d="M0 0h24v24H0V0z"></path></defs><clipPath id="b"><use xlink:href="#a" overflow="visible"></use></clipPath><path clip-path="url(#b)" d="M12 2C6.5 2 2 6.5 2 12s4.5 10 10 10 10-4.5 10-10S17.5 2 12 2zm4.2 14.2L11 13V7h1.5v5.2l4.5 2.7-.8 1.3z"></path></svg><a href="https://humbot.io/securities-registration-statement-simplified-form-s-3-mbot-robot-mblock-robot" rel="bookmark"><time class="entry-date published updated" datetime="2021-01-22T10:49:48+00:00">janvier 22, 2021</time></a></span><span class="cat-links"><svg class="svg-icon" width="16" height="16" aria-hidden="true" role="img" focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M10 4H4c-1.1 0-1.99.9-1.99 2L2 18c0 1.1.9 2 2 2h16c1.1 0 2-.9 2-2V8c0-1.1-.9-2-2-2h-8l-2-2z"></path><path d="M0 0h24v24H0z" fill="none"></path></svg><span class="screen-reader-text">Publié dans</span><a href="https://humbot.io/category/mbot-robot" rel="category tag">mbot robot</a></span> </footer><!-- .entry-footer --> </article><!-- #post-20493 --> <nav class="navigation post-navigation" role="navigation" aria-label="Publications"> <h2 class="screen-reader-text">Navigation de l’article</h2> <div class="nav-links"><div class="nav-previous"><a href="https://humbot.io/cadeaux-top-tech-stem-pour-les-adolescents-de-13-ans-et-plus-codage-robots-gadgets-fabrication-tech-age-kids-mbot-robot-mblock-robot" rel="prev"><span class="meta-nav" aria-hidden="true">Article précédent</span> <span class="screen-reader-text">Article précédent :</span> <br/><span class="post-title">Cadeaux Top Tech (STEM) pour les adolescents de 13 ans et plus Codage, robots, gadgets, fabrication | Tech Age Kids – mbot robot & mblock robot</span></a></div><div class="nav-next"><a href="https://humbot.io/microbot-medical-enrichit-le-comite-consultatif-scientifique-avec-des-radiologues-interventionnels-de-renommee-mondiale-mbot-robot-mblock-robot" rel="next"><span class="meta-nav" aria-hidden="true">Article suivant</span> <span class="screen-reader-text">Article suivant :</span> <br/><span class="post-title">Microbot Medical enrichit le Comité consultatif scientifique avec des radiologues interventionnels de renommée mondiale – mbot robot & mblock robot</span></a></div></div> </nav> <div id="comments" class="comments-area"> <div class="comments-title-wrap no-responses"> <h2 class="comments-title"> Laisser un commentaire </h2><!-- .comments-title --> </div><!-- .comments-title-flex --> <div id="respond" class="comment-respond"> <h3 id="reply-title" class="comment-reply-title"> <small><a rel="nofollow" id="cancel-comment-reply-link" href="/securities-registration-statement-simplified-form-s-3-mbot-robot-mblock-robot#respond" style="display:none;">Annuler la réponse</a></small></h3><form action="https://humbot.io/wp-comments-post.php" method="post" id="commentform" class="comment-form" novalidate><p class="comment-notes"><span id="email-notes">Votre adresse de messagerie ne sera pas publiée.</span> Les champs obligatoires sont indiqués avec <span class="required">*</span></p><p class="comment-form-comment"><label for="comment">Commentaire</label> <textarea id="comment" name="comment" cols="45" rows="5" maxlength="65525" required="required"></textarea></p><p class="comment-form-author"><label for="author">Nom <span class="required">*</span></label> <input id="author" name="author" type="text" value="" size="30" maxlength="245" required='required' /></p> <p class="comment-form-email"><label for="email">Adresse de messagerie <span class="required">*</span></label> <input id="email" name="email" type="email" value="" size="30" maxlength="100" aria-describedby="email-notes" required='required' /></p> <p class="comment-form-url"><label for="url">Site web</label> <input id="url" name="url" type="url" value="" size="30" maxlength="200" /></p> <p class="comment-form-cookies-consent"><input id="wp-comment-cookies-consent" name="wp-comment-cookies-consent" type="checkbox" value="yes" /> <label for="wp-comment-cookies-consent">Enregistrer mon nom, mon e-mail et mon site web dans le navigateur pour mon prochain commentaire.</label></p> <p class="form-submit"><input name="submit" type="submit" id="submit" class="submit" value="Laisser un commentaire" /> <input type='hidden' name='comment_post_ID' value='20493' id='comment_post_ID' /> <input type='hidden' name='comment_parent' id='comment_parent' value='0' /> </p></form> </div><!-- #respond --> </div><!-- #comments --> </main><!-- #main --> </div><!-- #primary --> </div><!-- #content --> <footer id="colophon" class="site-footer"> <aside class="widget-area" role="complementary" aria-label="Pied de page"> <div class="widget-column footer-widget-1"> <section id="search-2" class="widget widget_search"><form role="search" method="get" class="search-form" action="https://humbot.io/"> <label> <span class="screen-reader-text">Rechercher :</span> <input type="search" class="search-field" placeholder="Rechercher…" value="" name="s" /> </label> <input type="submit" class="search-submit" value="Rechercher" /> </form></section> <section id="recent-posts-2" class="widget widget_recent_entries"> <h2 class="widget-title">Articles récents</h2><nav role="navigation" aria-label="Articles récents"> <ul> <li> <a href="https://humbot.io/nouvelle-ligne-de-chaussures-imprimees-4d-fusio-3d-de-adidas-leaked-3dprint-com-mbot-robot-mblock-robot">Nouvelle ligne de chaussures imprimées 4D Fusio 3D de adidas Leaked – 3DPrint.com – mbot robot & mblock robot</a> </li> <li> <a href="https://humbot.io/construisez-votre-propre-robot-tout-terrain-3-en-1-avec-cet-ensemble-mbot-robot-mblock-robot">Construisez votre propre robot tout-terrain 3-en-1 avec cet ensemble – mbot robot & mblock robot</a> </li> <li> <a href="https://humbot.io/nous-pensons-que-microbot-medical-nasdaq-mbot-peut-fournir-des-conseils-pour-stimuler-la-croissance-de-lentreprise-mbot-robot-mblock-robot">Nous pensons que Microbot Medical (NASDAQ: MBOT) peut fournir des conseils pour stimuler la croissance de l’entreprise – mbot robot & mblock robot</a> </li> <li> <a href="https://humbot.io/doigts-de-prehension-du-robot-doux-et-sensibles-realises-avec-limpression-3d-multimedia-3dprint-com-mbot-robot-mblock-robot">Doigts de préhension du robot doux et sensibles réalisés avec l’impression 3D multimédia – 3DPrint.com – mbot robot & mblock robot</a> </li> <li> <a href="https://humbot.io/les-equipages-de-conduite-exemptes-de-la-legislation-canadienne-sur-la-quarantaine-mbot-robot-mblock-robot">Les équipages de conduite exemptés de la législation canadienne sur la quarantaine – mbot robot & mblock robot</a> </li> </ul> </nav></section><section id="recent-comments-2" class="widget widget_recent_comments"><h2 class="widget-title">Commentaires récents</h2><nav role="navigation" aria-label="Commentaires récents"><ul id="recentcomments"></ul></nav></section><section id="archives-2" class="widget widget_archive"><h2 class="widget-title">Archives</h2><nav role="navigation" aria-label="Archives"> <ul> <li><a href='https://humbot.io/2021/02'>février 2021</a></li> <li><a href='https://humbot.io/2021/01'>janvier 2021</a></li> <li><a href='https://humbot.io/2020/12'>décembre 2020</a></li> <li><a href='https://humbot.io/2020/11'>novembre 2020</a></li> <li><a href='https://humbot.io/2020/10'>octobre 2020</a></li> <li><a href='https://humbot.io/2020/09'>septembre 2020</a></li> </ul> </nav></section><section id="categories-2" class="widget widget_categories"><h2 class="widget-title">Catégories</h2><nav role="navigation" aria-label="Catégories"> <ul> <li class="cat-item cat-item-11"><a href="https://humbot.io/category/jeu-educatifs">jeux educatifs</a> </li> <li class="cat-item cat-item-2"><a href="https://humbot.io/category/mblock-robot">Mblock Robot</a> </li> <li class="cat-item cat-item-10"><a href="https://humbot.io/category/mbot-robot">mbot robot</a> </li> <li class="cat-item cat-item-25"><a href="https://humbot.io/category/robot-educatif">robot educatif</a> </li> </ul> </nav></section><section id="meta-2" class="widget widget_meta"><h2 class="widget-title">Méta</h2><nav role="navigation" aria-label="Méta"> <ul> <li><a href="https://humbot.io/wp-login.php">Connexion</a></li> <li><a href="https://humbot.io/feed">Flux des publications</a></li> <li><a href="https://humbot.io/comments/feed">Flux des commentaires</a></li> <li><a href="https://fr.wordpress.org/">Site de WordPress-FR</a></li> </ul> </nav></section> </div> </aside><!-- .widget-area --> <div class="site-info"> <a class="site-name" href="https://humbot.io/" rel="home">Jeu ducatif jouet robot et robot pdagogique</a>, <a href="https://fr.wordpress.org/" class="imprint"> Fièrement propulsé par WordPress. </a> </div><!-- .site-info --> </footer><!-- #colophon --> </div><!-- #page --> <script src='https://humbot.io/wp-includes/js/comment-reply.min.js?ver=5.5.3' id='comment-reply-js'></script> <script src='https://humbot.io/wp-includes/js/wp-embed.min.js?ver=5.5.3' id='wp-embed-js'></script> <script> /(trident|msie)/i.test(navigator.userAgent)&&document.getElementById&&window.addEventListener&&window.addEventListener("hashchange",function(){var t,e=location.hash.substring(1);/^[A-z0-9_-]+$/.test(e)&&(t=document.getElementById(e))&&(/^(?:a|select|input|button|textarea)$/i.test(t.tagName)||(t.tabIndex=-1),t.focus())},!1); </script> </body> </html>